Arenaza A, Diez R, Esteve J, Di Nicolantonio R, Gostkorzewicz J, Martínez C, Martínez Llinàs D, Martinez-Lopez J, Montesinos P, Moure-Fernández A, Sierra J, Vinent JL

ClinicoEconomics and Outcomes Research 2019, 11:683-694

Published Date: 13 November 2019

Original Research

Budget Impact Of Eltrombopag As First-Line Treatment For Severe Aplastic Anemia In The United States

Tremblay G, Said Q, Roy AN, Cai B, Ashton Garib S, Hearnden J, Forsythe A

ClinicoEconomics and Outcomes Research 2019, 11:673-681

Published Date: 12 November 2019

Original Research

Budget Impact Of Including Avelumab As A Second-Line Treatment For Locally Advanced Or Metastatic Urothelial Cancer In The United States: Commercial And Medicare Payer Perspectives

Kongnakorn T, Bharmal M, Kearney M, Phatak H, Benedict A, Bhanegaonkar A, Galsky M

ClinicoEconomics and Outcomes Research 2019, 11:659-672

Published Date: 8 November 2019

Perspectives

Moving Toward Universal Health Coverage: Four Decades Of Experience From The Iranian Health System

Alinia C, Davoodi Lahijan J

ClinicoEconomics and Outcomes Research 2019, 11:651-657

Published Date: 7 November 2019

Original Research

Cost-Effectiveness Of The SQ® Grass SLIT-Tablet In Children With Allergic Rhinitis: A German Payer Perspective

Vogelberg C, Hamelmann E, Wahn U, Domdey A, Pollock RF, Grand TS

ClinicoEconomics and Outcomes Research 2019, 11:637-649

Published Date: 6 November 2019

Original Research

A Cost-Effectiveness Analysis Of An Adenocarcinoma Risk Prediction Multi-Biomarker Assay For Patients With Barrett’s Esophagus

Hao J, Critchley-Thorne R, Diehl DL, Snyder SR

ClinicoEconomics and Outcomes Research 2019, 11:623-635

Published Date: 25 October 2019

Original Research

Estimation Of The Quality Of Life Benefits Associated With Treatment For Spinal Muscular Atrophy

Lloyd AJ, Thompson R, Gallop K, Teynor M

ClinicoEconomics and Outcomes Research 2019, 11:615-622

Published Date: 25 October 2019

Original Research

Value For Money In The Treatment Of Patients With Type 2 Diabetes Mellitus: Assessing The Long-Term Cost-Effectiveness Of IDegLira Versus iGlarLixi In Italy

Pöhlmann J, Montagnoli R, Lastoria G, Parekh W, Markert M, Hunt B

ClinicoEconomics and Outcomes Research 2019, 11:605-614

Published Date: 7 October 2019

Perspectives

Management Of Glaucoma In Developing Countries: Challenges And Opportunities For Improvement

Delgado MF, Abdelrahman AM, Terahi M, Miro Quesada Woll JJ, Gil-Carrasco F, Cook C, Benharbit M, Boisseau S, Chung E, Hadjiat Y, Gomes JAP

ClinicoEconomics and Outcomes Research 2019, 11:591-604

Published Date: 27 September 2019

Original Research

Health economic evaluation of peritoneal dialysis based on cost-effectiveness in Japan: a preliminary study

Takura T, Hiramatsu M, Nakamoto H, Kuragano T, Minakuchi J, Ishida H, Nakayama M, Takahashi S, Kawanishi H

ClinicoEconomics and Outcomes Research 2019, 11:579-590

Published Date: 25 September 2019

Original Research

Social Return On Investment For Patient Treated By Continuous Ambulatory Peritoneal Dialysis: A Case Study In Ubon Ratchathani Province, Thailand

Lophongpanit P, Tongsiri S, Thongprasert N

ClinicoEconomics and Outcomes Research 2019, 11:569-578

Published Date: 23 September 2019

Corrigendum

Evaluating the cost and clinical effectiveness of long-acting, injectable aripiprazole and paliperidone palmitate once a month in a real-world setting [Corrigendum]

Hodgson RE

ClinicoEconomics and Outcomes Research 2019, 11:567-568

Published Date: 9 September 2019

Original Research

Overall survival of glasdegib in combination with low-dose cytarabine, azacitidine, and decitabine among adult patients with previously untreated AML: comparative effectiveness using simulated treatment comparisons

Tremblay G, Westley T, Cappelleri JC, Arondekar B, Chan G, Bell TJ, Briggs A

ClinicoEconomics and Outcomes Research 2019, 11:551-565

Published Date: 6 September 2019

Original Research

Patient and economic burdens of postherpetic neuralgia in China

Yu SY, Fan BF, Yang F, DiBonaventura M, Chen YX, Li RY, King-Concialdi K, Kudel I, Hlavacek P, Hopps M, Udall M, Sadosky A, Cappelleri JC

ClinicoEconomics and Outcomes Research 2019, 11:539-550

Published Date: 3 September 2019

Original Research

Cost-consequence analysis for human recombinant growth hormone (r-hGH) treatment administered via different devices in children with growth hormone deficiency in Italy

Foo J, Maghnie M, Colao A, Vlachaki I, Colombo G

ClinicoEconomics and Outcomes Research 2019, 11:525-537

Published Date: 22 August 2019

Original Research

Evaluating the cost and clinical effectiveness of long-acting, injectable aripiprazole and paliperidone palmitate once a month in a real-world setting

Hodgson RE

ClinicoEconomics and Outcomes Research 2019, 11:517-524

Published Date: 13 August 2019

Corrigendum

HTA and innovative treatments evaluation: the case of metastatic castration-resistant prostate cancer [Corrigendum]

Bretoni A, Ferrario L, Foglia E

ClinicoEconomics and Outcomes Research 2019, 11:515-516

Published Date: 6 August 2019

Original Research

Characteristics and outcome of high-cost ICU patients

Aung YN, Nur AM, Ismail A, Aljunid SM

ClinicoEconomics and Outcomes Research 2019, 11:505-513

Published Date: 2 August 2019

Original Research

Cost-effectiveness of adding Endocuff® to standard colonoscopies for interval colorectal cancer screening

Yu TM, Tradonsky A, Tang J, Arnold RJG

ClinicoEconomics and Outcomes Research 2019, 11:487-504

Published Date: 31 July 2019

Original Research

A Canadian cost-effectiveness analysis of SAPIEN 3 transcatheter aortic valve implantation compared with surgery, in intermediate and high-risk severe aortic stenosis patients

Tarride JE, Luong T, Goodall G, Burke N, Blackhouse G

ClinicoEconomics and Outcomes Research 2019, 11:477-486

Published Date: 29 July 2019

Original Research

Burden of diabetes mellitus in patients with acromegaly treated with second-line pharmacotherapy in Spain

Sánchez-Cenizo L, Aller J, Martínez-Sesmero JM, Mir N, Peral C, Rubio-Rodríguez D, Rubio-Terrés C

ClinicoEconomics and Outcomes Research 2019, 11:465-475

Published Date: 22 July 2019

Original Research

Cost-effectiveness and budget impact analysis of viscosupplementation with hylan G-F 20 for knee and hip osteoarthritis

Migliore A, Integlia D, Pompilio G, Di Giuseppe F, Aru C, Brown T

ClinicoEconomics and Outcomes Research 2019, 11:453-464

Published Date: 22 July 2019

Original Research

Clinical and economic burden of head and neck cancer: a nationwide retrospective cohort study from France

Schernberg A, Sagaon-Teyssier L, Schwarzinger M

ClinicoEconomics and Outcomes Research 2019, 11:441-451

Published Date: 22 July 2019

Original Research

Untangling the clinical and economic burden of hospitalization for cardiac amyloidosis in the United States

Quock TP, Yan T, Tieu R, D'Souza A, Broder MS

ClinicoEconomics and Outcomes Research 2019, 11:431-439

Published Date: 15 July 2019

Original Research

Cost–benefit comparison of liraglutide and sitagliptin in the treatment of type 2 diabetes in Thailand

Deerochanawong C, Kosachunhanun N, Gadekar AV, Chotikanokrat P, Permsuwan U

ClinicoEconomics and Outcomes Research 2019, 11:423-430

Published Date: 11 July 2019

Original Research

The added burden of depression in patients with osteoarthritis in Japan

Tsuji T, Nakata K, Vietri J, Jaffe DH

ClinicoEconomics and Outcomes Research 2019, 11:411-421

Published Date: 20 June 2019

Review

Abatacept: from a budget impact model to cost-effectiveness analysis – data from RCT and real life

Benucci M, Damiani A, Manfredi M, Infantino M, Grossi V, Li Gobbi F

ClinicoEconomics and Outcomes Research 2019, 11:405-409

Published Date: 7 June 2019

Original Research

Cost-effectiveness analysis of baricitinib versus adalimumab for the treatment of moderate-to-severe rheumatoid arthritis in Spain

Schlueter M, Finn E, Díaz S, Dilla T, Inciarte-Mundo J, Fakhouri W

ClinicoEconomics and Outcomes Research 2019, 11:395-403

Published Date: 6 June 2019

Original Research

Heart failure hospitalization reduction and cost savings achieved by improved delivery of effective biventricular pacing: economic implications of the OLE study under the US setting

Hernández-Madrid A, Lu X, Tsintzos SI, Fagan DH, Klepfer RN, Matía R, Chung ES

ClinicoEconomics and Outcomes Research 2019, 11:385-393

Published Date: 6 June 2019

Original Research

Association of tumor location with economic outcomes and air leak complications in thoracic lobectomies: results from a national hospital billing dataset

Bhora F, Ghosh SK, Kassis E, Yoo A, Ramisetti S, Johnston SS, Rehmani S, Kalsekar I

ClinicoEconomics and Outcomes Research 2019, 11:373-383

Published Date: 6 June 2019

Original Research

Treatment patterns and economic outcomes in patients with juvenile idiopathic arthritis

Marshall A, Gupta K, Pazirandeh M, Bonafede M, McMorrow D

ClinicoEconomics and Outcomes Research 2019, 11:361-371

Published Date: 31 May 2019

Original Research

Budget impact model of avelumab in patients with metastatic merkel cell carcinoma in the US

Bharmal M, Kearney M, Zheng Y, Phatak H

ClinicoEconomics and Outcomes Research 2019, 11:349-359

Published Date: 22 May 2019

Original Research

An iron triangle ROI model for health care

van der Goes DN, Edwardson N, Rayamajhee V, Hollis C, Hunter D

ClinicoEconomics and Outcomes Research 2019, 11:335-348

Published Date: 10 May 2019

Review

Electronic referral systems in health care: a scoping review

Azamar-Alonso A, Costa AP, Huebner LA, Tarride JE

ClinicoEconomics and Outcomes Research 2019, 11:325-333

Published Date: 6 May 2019

Original Research

The impact of increased post-progression survival on the cost-effectiveness of interventions in oncology

Retzler J, Davies H, Jenks M, Kiff C, Taylor M

ClinicoEconomics and Outcomes Research 2019, 11:309-324

Published Date: 3 May 2019

Original Research

Cost-effectiveness of fractional exhaled nitric oxide (FeNO) measurement in predicting response to omalizumab in asthma

Brooks EA, Massanari M, Hanania NA, Weiner DJ

ClinicoEconomics and Outcomes Research 2019, 11:301-307

Published Date: 17 April 2019

Original Research

HTA and innovative treatments evaluation: the case of metastatic castration-resistant prostate cancer

Bretoni A, Ferrario L, Foglia E

ClinicoEconomics and Outcomes Research 2019, 11:283-300

Published Date: 17 April 2019

Original Research

Cost of achieving HbA1c and weight loss treatment targets with IDegLira vs insulin glargine U100 plus insulin aspart in the USA

Billings LK, Mocarski M, Basse A, Hunt B, Valentine WJ, Jodar E

ClinicoEconomics and Outcomes Research 2019, 11:271-282

Published Date: 21 March 2019

Original Research

Cost-effectiveness model for a hypothetical monotherapy vs standard of care in adult patients with treatment-resistant depression

Wang ST, Anderson IM, Mitchell D, Johnson SJ, Shiozawa A

ClinicoEconomics and Outcomes Research 2019, 11:257-270

Published Date: 14 March 2019

Original Research

Cost-of-illness of knee osteoarthritis: potential cost savings by not undergoing arthroplasty within the first 2 years

Ong KL, Runa M, Lau E, Altman RD

ClinicoEconomics and Outcomes Research 2019, 11:245-255

Published Date: 14 March 2019

Original Research

Health-related quality of life outcomes, economic burden, and associated costs among diagnosed and undiagnosed depression patients in Japan

Yamabe K, Liebert R, Flores N, Pashos CL

ClinicoEconomics and Outcomes Research 2019, 11:233-243

Published Date: 12 March 2019

Original Research

Health-related quality of life outcomes and economic burden of inflammatory bowel disease in Japan

Yamabe K, Liebert R, Flores N, Pashos CL

ClinicoEconomics and Outcomes Research 2019, 11:221-232

Published Date: 12 March 2019

Original Research

Relative value assessment: characterizing the benefit of oncology therapies through diverse survival metrics from a US perspective

Macaulay R, Ahuja A, Ademisoye E, Juarez-Garcia A, Shaw JW

ClinicoEconomics and Outcomes Research 2019, 11:199-219

Published Date: 19 March 2019

Original Research

Reduction of direct costs in high-risk lumbar discectomy patients during the 90-day post-operative period through annular closure

Thaci B, McGirt MJ, Ammerman JM, Thomé C, Kim KD, Ament JD

ClinicoEconomics and Outcomes Research 2019, 11:191-197

Published Date: 28 February 2019

Original Research

Health care utilization and costs following amplified versus non-amplified molecular probe testing for symptomatic patients with suspected vulvovaginitis: a US commercial payer population

Ackerman SJ, Knight T, Wahl PM, Cartwright CP

ClinicoEconomics and Outcomes Research 2019, 11:179-189

Published Date: 20 February 2019

Original Research

A cost-consequence analysis of parecoxib and opioids vs opioids alone for postoperative pain: Chinese perspective

Barra M, Remák E, Liu DD, Xie L, Abraham L, Sadosky AB

ClinicoEconomics and Outcomes Research 2019, 11:169-177

Published Date: 22 February 2019

Original Research

Cost-effectiveness of secukinumab compared to other biologics in the treatment of ankylosing spondylitis in Finland

Purmonen T, Puolakka K, Mishra D, Gunda P, Martikainen J

ClinicoEconomics and Outcomes Research 2019, 11:159-168

Published Date: 15 February 2019

Original Research

Catastrophic health expenditure of Vietnamese patients with gallstone diseases – a case for health insurance policy revaluation

Tran BX, Tran TD, Nathan N, Ngo CQ, Nguyen LT, Nguyen LH, Nguyen HLT, Nguyen CT, Do HP, Nguyen THT, Tran TT, Thai TPT, Dang AK, Nguyen NB, Latkin CA, Ho CSH, Ho RCM

ClinicoEconomics and Outcomes Research 2019, 11:151-158

Published Date: 11 February 2019

Original Research

Ninety-day postoperative cost in primary total hip arthroplasty: an economic model comparing surgical approaches

Miller LE, Martinson MS, Gondusky JS, Kamath AF, Boettner F, Bhattacharyya SK

ClinicoEconomics and Outcomes Research 2019, 11:145-149

Published Date: 7 February 2019

Original Research

Length of stay, mortality, and readmissions among Medicare cancer patients treated with glucarpidase and conventional care: a retrospective study

Demiralp B, Koenig L, Kala J, Feng C, Hamlett EG, Steele-Adjognon M, Ward S

ClinicoEconomics and Outcomes Research 2019, 11:129-144

Published Date: 7 February 2019

Original Research

Sarilumab monotherapy compared with adalimumab monotherapy for the treatment of moderately to severely active rheumatoid arthritis: an analysis of incremental cost per effectively treated patient

Fournier M, Chen C, Kuznik A, Proudfoot C, Mallya UG, Michaud K

ClinicoEconomics and Outcomes Research 2019, 11:117-128

Published Date: 5 February 2019

Original Research

Economic impact of pharmacist interventions on correction of stress-related mucosal damage prophylaxis practice

Mahmoudi L, Mohammadi R, Niknam R

ClinicoEconomics and Outcomes Research 2019, 11:111-116

Published Date: 25 January 2019

Original Research

Comparative analysis of US real-world dosing patterns and direct infusion-related costs for matched cohorts of rheumatoid arthritis patients treated with infliximab or intravenous golimumab

Ellis LA, Malangone-Monaco E, Varker H, Stetsovsky D, Kubacki M, DeHoratius RJ, Kafka S

ClinicoEconomics and Outcomes Research 2019, 11:99-110

Published Date: 15 January 2019

Original Research

Health-related quality of life in acute myeloid leukemia patients not eligible for intensive chemotherapy: results of a systematic literature review

Forsythe A, Kwon CS, Bell T, Smith TA, Arondekar B

ClinicoEconomics and Outcomes Research 2019, 11:87-98

Published Date: 14 January 2019

Corrigendum

Budget impact analysis of sarilumab for the treatment of rheumatoid arthritis in patients with an inadequate response to conventional synthetic DMARD or TNF inhibitor therapies [Corrigendum]

Ferrufino CP, Munakata J, Wei W, Proudfoot C, Kuznik A, Boklage SH, Chen C

ClinicoEconomics and Outcomes Research 2019, 11:83-85

Published Date: 14 January 2019

Original Research

Cost-effectiveness of sensor-augmented insulin pump therapy vs continuous subcutaneous insulin infusion in patients with type 1 diabetes in the Netherlands

Roze S, Smith-Palmer J, de Portu S, Dalbaere A, de Brouwer B, de Valk HW

ClinicoEconomics and Outcomes Research 2019, 11:73-82

Published Date: 14 January 2019

Original Research

Health-related outcomes, health care resource utilization, and costs of multiple sclerosis in Japan compared with US and five EU countries

Yamabe K, DiBonaventura MD, Pashos CL

ClinicoEconomics and Outcomes Research 2019, 11:61-71

Published Date: 7 January 2019

Original Research

Impact of migraine on health care utilization and expenses in obese adults: a US population-based study

Wu J, Davis-Ajami ML, Lu ZK

ClinicoEconomics and Outcomes Research 2019, 11:51-59

Published Date: 31 December 2018

Original Research

Systematic literature review of treatment patterns for venous thromboembolism patients during transitions from inpatient to post-discharge settings

Trocio J, Rosen VM, Gupta A, Dina O, Vo L, Hlavacek P, Rosenblatt L

ClinicoEconomics and Outcomes Research 2019, 11:23-49

Published Date: 19 December 2018

Original Research

Indirect costs associated with premature mortality among those with veno-occlusive disease/sinusoidal obstruction syndrome with multiorgan dysfunction post-hematopoietic stem-cell-transplant

Zhou ZY, Tang W, Villa KF

ClinicoEconomics and Outcomes Research 2019, 11:13-22

Published Date: 17 December 2018

Original Research

A US hospital budget impact analysis of a skin closure system compared with standard of care in hip and knee arthroplasty

Sadik K, Flener J, Gargiulo J, Post Z, Wurzelbacher S, Hogan A, Hollmann S, Ferko N

ClinicoEconomics and Outcomes Research 2019, 11:1-11

Published Date: 17 December 2018

Review

The number needed to treat and relevant between-trial comparisons of competing interventions

Jansen JP, Khalid JM, Smyth MD, Patel H

ClinicoEconomics and Outcomes Research 2018, 10:865-871

Published Date: 14 December 2018

Original Research

The cost impact to Medicare of shifting treatment of worsening heart failure from inpatient to outpatient management settings

Fitch K, Lau J, Engel T, Medicis JJ, Mohr JF, Weintraub WS

ClinicoEconomics and Outcomes Research 2018, 10:855-863

Published Date: 14 December 2018

Review

A methodological review of national and transnational pharmaceutical budget impact analysis guidelines for new drug submissions

Foroutan N, Tarride JE, Xie F, Levine M

ClinicoEconomics and Outcomes Research 2018, 10:821-854

Published Date: 26 November 2018

Original Research

Budget impact analysis of sarilumab for the treatment of rheumatoid arthritis in patients with an inadequate response to conventional synthetic DMARD or TNF inhibitor therapies

Ferrufino CP, Munakata J, Wei W, Proudfoot C, Kuznik A, Boklage SH, Chen C

ClinicoEconomics and Outcomes Research 2018, 10:805-819

Published Date: 16 November 2018

Original Research

Cost-effectiveness and budget impact of liraglutide in type 2 diabetes patients with elevated cardiovascular risk: a US-managed care perspective

Shah D, Risebrough NA, Perdrizet J, Iyer NN, Gamble C, Dang-Tan T

ClinicoEconomics and Outcomes Research 2018, 10:791-803

Published Date: 14 November 2018

Original Research

Cost-effectiveness analysis of ribociclib versus palbociclib in the first-line treatment of HR+/HER2– advanced or metastatic breast cancer in Spain

Galve-Calvo E, González-Haba E, Gostkorzewicz J, Martínez I, Pérez-Mitru A

ClinicoEconomics and Outcomes Research 2018, 10:773-790

Published Date: 14 November 2018

Original Research

Impact of postcolectomy adhesion-related complications on healthcare utilization

Etter K, Sutton N, Wei D, Yoo A

ClinicoEconomics and Outcomes Research 2018, 10:761-771

Published Date: 14 November 2018

Original Research

Cost effectiveness of ixekizumab versus secukinumab in the treatment of moderate-to-severe plaque psoriasis in Spain

Johansson E, Nuñez M, Svedbom A, Dilla T, Hartz S

ClinicoEconomics and Outcomes Research 2018, 10:747-759

Published Date: 12 November 2018

Original Research

Cost-utility of surgical sutureless bioprostheses vs TAVI in aortic valve replacement for patients at intermediate and high surgical risk

Povero M, Miceli A, Pradelli L, Ferrarini M, Pinciroli M, Glauber M

ClinicoEconomics and Outcomes Research 2018, 10:733-745

Published Date: 8 November 2018

Corrigendum

Impact of comorbidity on the risk and cost of hospitalization in HIV-infected patients: real-world data from Abruzzo Region [Corrigendum]

Cammarota S, Citarella A, Manzoli L, Flacco ME, Parruti G

ClinicoEconomics and Outcomes Research 2018, 10:731-732

Published Date: 8 November 2018

Original Research

Multiple sclerosis patients who are stable on interferon therapy show better outcomes when staying on same therapy than patients who switch to another interferon

Chen C, Wu N, Watson C

ClinicoEconomics and Outcomes Research 2018, 10:723-730

Published Date: 2 November 2018

Original Research

Cost-consequence model comparing eltrombopag and romiplostim in pediatric patients with chronic immune thrombocytopenia

Tremblay G, Dolph M, Bhor M, Said Q, Roy A, Elliott B, Briggs A

ClinicoEconomics and Outcomes Research 2018, 10:715-721

Published Date: 5 November 2018

Original Research

Cost-consequence model comparing eltrombopag versus romiplostim for adult patients with chronic immune thrombocytopenia

Tremblay G, Dolph M, Bhor M, Said Q, Elliott B, Briggs A

ClinicoEconomics and Outcomes Research 2018, 10:705-713

Published Date: 1 November 2018

Original Research

Incremental health care resource utilization and expenditures associated with autosomal dominant polycystic kidney disease

Iyer NN, Vendetti NJ, Levy DI, Mardekian J, Mychaskiw MA, Thomas III J

ClinicoEconomics and Outcomes Research 2018, 10:693-703

Published Date: 31 October 2018

Review

Burden of cancer pain in developing countries: a narrative literature review

Li Z, Aninditha T, Griene B, Francis J, Renato P, Serrie A, Umareddy I, Boisseau S, Hadjiat Y

ClinicoEconomics and Outcomes Research 2018, 10:675-691

Published Date: 2 November 2018

Original Research

Economic benefits of implementing patient-centered medical home among patients with hypertension

Almalki ZS, Alotaibi AA, Alzaidi WS, Alghamdi AA, Bahowirth AM, Alsalamah NM

ClinicoEconomics and Outcomes Research 2018, 10:665-673

Published Date: 31 October 2018

Original Research

Economic analysis of pharmacist-administered influenza vaccines in Ontario, Canada

O'Reilly DJ, Blackhouse G, Burns S, Bowen JM, Burke N, Mehltretter J, Waite NM, Houle SKD

ClinicoEconomics and Outcomes Research 2018, 10:655-663

Published Date: 24 October 2018

Editorial

Health-related outcomes and economic burden in Japan: focus on inflammatory bowel disease, multiple sclerosis, and depression

Yamabe K

ClinicoEconomics and Outcomes Research 2018, 10:653-654

Published Date: 23 October 2018

Original Research

Sacroiliac joint fusion health care cost comparison prior to and following surgery: an administrative claims analysis

Buysman EK, Halpern R, Polly DW

ClinicoEconomics and Outcomes Research 2018, 10:643-651

Published Date: 17 October 2018

Original Research

Real-world analysis of cost, health care resource utilization, and supportive care in Hodgkin lymphoma patients with frontline failure

Bonafede M, Feliciano J, Cai Q, Noxon V, Princic N, Richhariya A, Straus DJ

ClinicoEconomics and Outcomes Research 2018, 10:629-641

Published Date: 17 October 2018

Original Research

Impact of antiepileptic-drug treatment burden on health-care-resource utilization and costs

Rajagopalan K, Candrilli SD, Ajmera M

ClinicoEconomics and Outcomes Research 2018, 10:619-627

Published Date: 16 October 2018

Original Research

The role of a best practice alert in the electronic medical record in reducing repetitive lab tests

Bejjanki H, Mramba LK, Beal SG, Radhakrishnan N, Bishnoi R, Shah C, Agrawal N, Harris N, Leverence R, Rand K

ClinicoEconomics and Outcomes Research 2018, 10:611-618

Published Date: 8 October 2018

Clinical Trial Report

A single blind, multicenter, randomized controlled trial to evaluate the effectiveness and cost of a novel nutraceutical (LopiGLIK®) lowering cardiovascular disease risk

Manfrin A, Trimarco V, Manzi MV, Rozza F, Izzo R

ClinicoEconomics and Outcomes Research 2018, 10:601-609

Published Date: 8 October 2018

Original Research

Comparison of real-world clinical and economic outcomes between the ThermoCool® SF and ThermoCool® catheters in patients undergoing radiofrequency catheter ablation for atrial fibrillation

Chinitz L, Goldstein LJ, Barnow A, Maccioni S, Daskiran M, Kalsekar I, Khanna R

ClinicoEconomics and Outcomes Research 2018, 10:587-599

Published Date: 4 October 2018

Original Research

Does knowledge of patient non-compliance change prescribing behavior in the real world? A claims-based analysis of patients with serious mental illness

Shafrin J, Bognar K, Everson K, Brauer M, Lakdawalla DN, Forma FM

ClinicoEconomics and Outcomes Research 2018, 10:573-585

Published Date: 2 October 2018

Original Research

Societal costs due to meningococcal disease: a national registry-based study

Gustafsson N, Stallknecht SE, Skovdal M, Poulsen PB, Østergaard L

ClinicoEconomics and Outcomes Research 2018, 10:563-572

Published Date: 2 October 2018

Original Research

Impact of a pharmacist-led diabetes management on outcomes, utilization, and cost

Maeng DD, Graham J, Bogart M, Hao J, Wright EA

ClinicoEconomics and Outcomes Research 2018, 10:551-562

Published Date: 24 September 2018

Original Research

Cost-effectiveness analysis of treatment timing considering the future entry of lower-cost generics for hepatitis C

Heath K

ClinicoEconomics and Outcomes Research 2018, 10:539-550

Published Date: 20 September 2018

Original Research

Cost of acute cough in Italian children

Dal Negro RW, Turco P, Povero M

ClinicoEconomics and Outcomes Research 2018, 10:529-537

Published Date: 17 September 2018

Original Research

Propensity score matching comparison of laparoscopic versus open surgery for rectal cancer in a middle-income country: short-term outcomes and cost analysis

Tayar DO, Ribeiro Jr U, Cecconello I, Magalhães TM, Simões CM, Auler Jr JOC

ClinicoEconomics and Outcomes Research 2018, 10:521-527

Published Date: 12 September 2018

Original Research

Cost-effectiveness analysis of voriconazole, fluconazole, and amphotericin B for invasive fungal infections following allogeneic hematopoietic stem cell transplantation in Mexico

Morfín-Otero R, Alvarado-Ibarra M, Rodriguez-Noriega E, Resendiz-Sanchez J, Patel DA, Stephens JM, Di Fusco M, Mendoza CF, Charbonneau C

ClinicoEconomics and Outcomes Research 2018, 10:511-520

Published Date: 6 September 2018

Original Research

Cost–consequence analysis of fluticasone furoate/vilanterol 92/22 mcg for the management of COPD in the Spanish NHS

Vallejo-Aparicio LA, Peces-Barba G, Gil A, Huerta Hernandez A

ClinicoEconomics and Outcomes Research 2018, 10:501-510

Published Date: 5 September 2018

Original Research

Incidence of febrile neutropenia during chemotherapy among patients with nonmyeloid cancer receiving filgrastim vs a filgrastim biosimilar

Schwartzberg LS, Lal LS, Balu S, Campbell K, Brekke L, Elliott C, Korrer S

ClinicoEconomics and Outcomes Research 2018, 10:493-500

Published Date: 3 September 2018

Original Research

Budget impact model of secukinumab for the treatment of moderate-to-severe psoriasis, psoriatic arthritis, and ankylosing spondylitis in Italy: a cross-indication initiative

Colombo GL, Di Matteo S, Martinotti C, Jugl SM, Gunda P, Naclerio M, Bruno GM

ClinicoEconomics and Outcomes Research 2018, 10:477-491

Published Date: 30 August 2018

Original Research

Obesity in Germany and Italy: prevalence, comorbidities, and associations with patient outcomes

DiBonaventura M, Nicolucci A, Meincke H, Le Lay A, Fournier J

ClinicoEconomics and Outcomes Research 2018, 10:457-475

Published Date: 24 August 2018

Original Research

Relapse prevention: a cost-effectiveness analysis of brexpiprazole treatment in adult patients with schizophrenia in the USA

Aigbogun MS, Liu S, Kamat SA, Sapin C, Duhig AM, Citrome L

ClinicoEconomics and Outcomes Research 2018, 10:443-456

Published Date: 16 August 2018

Original Research

Cost of opioid medication abuse with and without tampering in the USA

Vietri J, Masters ET, Barsdorf AI, Mardekian J

ClinicoEconomics and Outcomes Research 2018, 10:433-442

Published Date: 10 August 2018

Original Research

The burden of cystic fibrosis in the Medicaid population

Hassan M, Bonafede MM, Limone BL, Hodgkins P, Sawicki GS

ClinicoEconomics and Outcomes Research 2018, 10:423-431

Published Date: 25 July 2018

Original Research

Cost-minimization analysis of degludec/liraglutide versus glargine/aspart: economic implications of the DUAL VII study outcomes

Torre E, Bruno GM, Di Matteo S, Martinotti C, Oselin M, Valentino MC, Parodi A, Bottaro LC, Colombo GL

ClinicoEconomics and Outcomes Research 2018, 10:413-421

Published Date: 26 July 2018

Review

Procedure costs associated with the use of Harmonic devices compared to conventional techniques in various surgeries: a systematic review and meta-analysis

Cheng H, Clymer JW, Qadeer RA, Ferko N, Sadeghirad B, Cameron CG, Amaral JF

ClinicoEconomics and Outcomes Research 2018, 10:399-412

Published Date: 24 July 2018

Original Research

Impact of comorbidity on the risk and cost of hospitalization in HIV-infected patients: real-world data from Abruzzo Region

Cammarota S, Citarella A, Manzoli L, Flacco ME, Parruti G

ClinicoEconomics and Outcomes Research 2018, 10:389-398

Published Date: 23 July 2018

Original Research

Health-care utilization and outcomes of patients at high risk of invasive fungal infection

Fu R, Gundrum J, Sung AH

ClinicoEconomics and Outcomes Research 2018, 10:371-387

Published Date: 12 July 2018

Original Research

A cost–benefit analysis of smoking cessation prescription coverage from a US payer perspective

Baker CL, Ding Y, Ferrufino CP, Kowal S, Tan J, Subedi P

ClinicoEconomics and Outcomes Research 2018, 10:359-370

Published Date: 16 July 2018

Original Research

Post-lumbar discectomy reoperations that are associated with poor clinical and socioeconomic outcomes can be reduced through use of a novel annular closure device: results from a 2-year randomized controlled trial

Klassen PD, Hsu WK, Martens F, Inzana JA, van den Brink WA, Groff MW, Thomé C

ClinicoEconomics and Outcomes Research 2018, 10:349-357

Published Date: 26 June 2018

Original Research

Evaluation of statin utilization in the Republic of Macedonia during 2013–2016

Naumovska Z, Nestorovska AK, Grozdanova A, Hristova K, Dimovski A, Suturkova L, Sterjev Z

ClinicoEconomics and Outcomes Research 2018, 10:339-347

Published Date: 26 June 2018

Original Research

Cost-effectiveness analysis of treating transplant-eligible multiple myeloma patients in Macedonia

Qerimi V, Kapedanovska Nestorovska A, Sterjev Z, Genadieva-Stavric S, Suturkova L

ClinicoEconomics and Outcomes Research 2018, 10:327-338

Published Date: 20 June 2018

Original Research

The cost of dysphagia in geriatric patients

Westmark S, Melgaard D, Rethmeier LO, Ehlers LH

ClinicoEconomics and Outcomes Research 2018, 10:321-326

Published Date: 6 June 2018

Review

A systematic literature review of the clinical and health economic burden of schizophrenia in privately insured patients in the United States

Zhang W, Amos TB, Gutkin SW, Lodowski N, Giegerich E, Joshi K

ClinicoEconomics and Outcomes Research 2018, 10:309-320

Published Date: 8 June 2018

Original Research

A comparison between WHODAS 2.0 and Modified Barthel Index: which tool is more suitable for assessing the disability and the recovery rate in orthopedic rehabilitation?

Galli T, Mirata P, Foglia E, Croce D, Porazzi E, Ferrario L, Ricci E, Garagiola E, Pagani R, Banfi G

ClinicoEconomics and Outcomes Research 2018, 10:301-307

Published Date: 5 June 2018

Original Research

Early introduction of a semi-elemental formula may be cost saving compared to a polymeric formula among critically ill patients requiring enteral nutrition: a cohort cost–consequence model

Curry AS, Chadda S, Danel A, Nguyen DL

ClinicoEconomics and Outcomes Research 2018, 10:293-300

Published Date: 5 June 2018

Original Research

Cost-effectiveness of pulse-echo ultrasonometry in osteoporosis management

Soini E, Riekkinen O, Kröger H, Mankinen P, Hallinen T, Karjalainen JP

ClinicoEconomics and Outcomes Research 2018, 10:279-292

Published Date: 29 May 2018

Original Research

Economic evaluation of point-of-care testing in the remote primary health care setting of Australia’s Northern Territory

Spaeth BA, Kaambwa B, Shephard MDS, Omond R

ClinicoEconomics and Outcomes Research 2018, 10:269-277

Published Date: 29 May 2018

Original Research

Claims-based proxies of patient instability among commercially insured adults with schizophrenia

Ruetsch C, Un H, Waters HC

ClinicoEconomics and Outcomes Research 2018, 10:259-267

Published Date: 7 May 2018

Original Research

Prevalence of antibiotic prescription in southern Italian outpatients: real-world data analysis of socioeconomic and sociodemographic variables at a municipality level

Russo V, Monetti VM, Guerriero F, Trama U, Guida A, Menditto E, Orlando V

ClinicoEconomics and Outcomes Research 2018, 10:251-258

Published Date: 3 May 2018

Original Research

Cost-effectiveness comparison of cabozantinib with everolimus, axitinib, and nivolumab in the treatment of advanced renal cell carcinoma following the failure of prior therapy in England

Meng J, Lister J, Vataire AL, Casciano R, Dinet J

ClinicoEconomics and Outcomes Research 2018, 10:243-250

Published Date: 23 April 2018

Original Research

Intermittent pneumatic compression is a cost-effective method of orthopedic postsurgical venous thromboembolism prophylaxis

Saunders R, Comerota AJ, Ozols A, Torrejon Torres R, Ho KM

ClinicoEconomics and Outcomes Research 2018, 10:231-241

Published Date: 19 April 2018

Original Research

An evaluation of the budget impact of a new 20% subcutaneous immunoglobulin (Ig20Gly) for the management of primary immunodeficiency diseases in Switzerland

Pollock RF, Meckley LM

ClinicoEconomics and Outcomes Research 2018, 10:223-229

Published Date: 10 April 2018

Original Research

The economic and clinical burden of early versus late initiation of celecoxib among patients with osteoarthritis

Shelbaya A, Solem CT, Walker C, Wan Y, Johnson C, Cappelleri JC

ClinicoEconomics and Outcomes Research 2018, 10:213-222

Published Date: 6 April 2018

Original Research

Clinical outcomes and health care utilization pre- and post-laparoscopic radiofrequency ablation of symptomatic fibroids and laparoscopic myomectomy: a randomized trial of uterine-sparing techniques (TRUST) in Canada

Rattray DD, Weins L, Regush LC, Bowen JM, O'Reilly D, Thiel JA

ClinicoEconomics and Outcomes Research 2018, 10:201-212

Published Date: 5 April 2018

Original Research

Clinical and economic impact of the 21-gene recurrence score assay in adjuvant therapy decision making in patients with early-stage breast cancer: pooled analysis in 4 Basque Country university hospitals

Martínez del Prado P, Alvarez-López I, Domínguez-Fernández S, Plazaola A, Ibarrondo O, Galve-Calvo E, Ancizar-Lizarraga N, Gutierrez-Toribio M, Lahuerta-Martínez A, Mar J

ClinicoEconomics and Outcomes Research 2018, 10:189-199

Published Date: 19 March 2018

Original Research

Cost analysis of a growth guidance system compared with traditional and magnetically controlled growing rods for early-onset scoliosis: a US-based integrated health care delivery system perspective

Luhmann SJ, McAughey EM, Ackerman SJ, Bumpass DB, McCarthy RE

ClinicoEconomics and Outcomes Research 2018, 10:179-187

Published Date: 16 March 2018

Original Research

Cost utility, budget impact, and scenario analysis of racecadotril in addition to oral rehydration for acute diarrhea in children in Malaysia

Rautenberg TA, Zerwes U, Lee WS

ClinicoEconomics and Outcomes Research 2018, 10:169-178

Published Date: 15 March 2018

Original Research

Analysis of utilization patterns and associated costs of the breast imaging and diagnostic procedures after screening mammography

Vlahiotis A, Griffin B, Stavros AT, Margolis J

ClinicoEconomics and Outcomes Research 2018, 10:157-167

Published Date: 26 March 2018

Corrigendum

Cost analysis of pulmonary lobectomy procedure: comparison of stapler versus precision dissection and sealant [Corrigendum]

Droghetti A, Marulli G, Vannucci J, Giovanardi M, Bottoli MC, Ragusa M, Muriana G

ClinicoEconomics and Outcomes Research 2018, 10:155-156

Published Date: 13 March 2018

Original Research

Modeling the economic outcomes of immuno-oncology drugs: alternative model frameworks to capture clinical outcomes

Gibson EJ, Begum N, Koblbauer I, Dranitsaris G, Liew D, McEwan P, Tahami Monfared AA, Yuan Y, Juarez-Garcia A, Tyas D, Lees M

ClinicoEconomics and Outcomes Research 2018, 10:139-154

Published Date: 8 March 2018

Original Research

Clinical and economic burden of idiopathic pulmonary fibrosis in Quebec, Canada

Tarride JE, Hopkins RB, Burke N, Guertin JR, O'Reilly D, Fell CD, Dion G, Kolb M

ClinicoEconomics and Outcomes Research 2018, 10:127-137

Published Date: 22 February 2018

Original Research

Early laparoscopic cholecystectomy is more cost-effective than delayed laparoscopic cholecystectomy in the treatment of acute cholecystitis

Kerwat D, Zargaran A, Bharamgoudar R, Arif N, Bello G, Sharma B, Kerwat R

ClinicoEconomics and Outcomes Research 2018, 10:119-125

Published Date: 19 February 2018

Original Research

A cost-utility analysis of small bite sutures versus large bite sutures in the closure of midline laparotomies in the United Kingdom National Health Service

Gokani SA, Elmqvist KO, El-Koubani O, Ash J, Biswas SK, Rigaudy M

ClinicoEconomics and Outcomes Research 2018, 10:105-117

Published Date: 19 February 2018

Original Research

Oral versus intravenous iron therapy in patients with inflammatory bowel disease and iron deficiency with and without anemia in Germany – a real-world evidence analysis

Stein J, Haas JS, Ong SH, Borchert K, Hardt T, Lechat E, Nip K, Foerster D, Braun S, Baumgart DC

ClinicoEconomics and Outcomes Research 2018, 10:93-103

Published Date: 5 February 2018

Original Research

Systematic review of health state utility values for acute myeloid leukemia

Forsythe A, Brandt PS, Dolph M, Patel S, Rabe APJ, Tremblay G

ClinicoEconomics and Outcomes Research 2018, 10:83-92

Published Date: 25 January 2018

Original Research

The preventive effect on respiratory tract infections of Oscillococcinum®. A cost-effectiveness analysis

Colombo GL, Di Matteo S, Martinotti C, Oselin M, Bruno GM, Beghi GM

ClinicoEconomics and Outcomes Research 2018, 10:75-82

Published Date: 23 January 2018

Original Research

A cost-effectiveness analysis of varenicline for smoking cessation using data from the EAGLES trial

Baker CL, Pietri G

ClinicoEconomics and Outcomes Research 2018, 10:67-74

Published Date: 19 January 2018

Original Research

Pain associated with health and economic burden in France: results from recent National Health and Wellness Survey data

Hadjiat Y, Serrie A, Treves R, Chomier B, Geranton L, Billon S

ClinicoEconomics and Outcomes Research 2018, 10:53-65

Published Date: 18 January 2018

Original Research

Economic evaluation of spondyloarthritis: economic impact of diagnostic delay in Italy

Mennini FS, Viti R, Marcellusi A, Sciattella P, Viapiana O, Rossini M

ClinicoEconomics and Outcomes Research 2018, 10:45-51

Published Date: 10 January 2018

Original Research

Cost-effectiveness analysis of six therapies for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia

Ulchaker JC, Martinson MS

ClinicoEconomics and Outcomes Research 2018, 10:29-43

Published Date: 29 December 2017

Review

Epidemiology, associated burden, and current clinical practice for the diagnosis and management of Alzheimer’s disease in Japan

Montgomery W, Ueda K, Jorgensen M, Stathis S, Cheng Y, Nakamura T

ClinicoEconomics and Outcomes Research 2018, 10:13-28

Published Date: 28 December 2017

Original Research

Clinical and economic outcomes of a "high-touch" clinical management program for intravenous immunoglobulin therapy

Zhu J, Kirkham HS, Ayer G, Chen CC, Wade RL, Karkare SU, Robson CH, Orange JS

ClinicoEconomics and Outcomes Research 2018, 10:1-12

Published Date: 19 December 2017

Original Research

"De-escalation" strategy using micafungin for the treatment of systemic Candida infections: budget impact in France and Germany

van Engen A, Casamayor M, Kim S, Watt M, Odeyemi I

ClinicoEconomics and Outcomes Research 2017, 9:763-774

Published Date: 5 December 2017

Original Research

Cost-effectiveness analysis of IDegLira versus basal-bolus insulin for patients with type 2 diabetes in the Slovak health system

Psota M, Psenkova MB, Racekova N, Ramirez de Arellano A, Vandebrouck T, Hunt B

ClinicoEconomics and Outcomes Research 2017, 9:749-762

Published Date: 12 December 2017

Original Research

Biological therapy utilization, switching, and cost among patients with psoriasis: retrospective analysis of administrative databases in Southern Italy

Guerriero F, Orlando V, Monetti VM, Russo V, Menditto E

ClinicoEconomics and Outcomes Research 2017, 9:741-748

Published Date: 1 December 2017

Review

Early intervention in the management of pulmonary arterial hypertension: clinical and economic outcomes

Burger CD, Ghandour M, Padmanabhan Menon D, Helmi H, Benza RL

ClinicoEconomics and Outcomes Research 2017, 9:731-739

Published Date: 24 November 2017

Perspectives

Do reimbursement recommendation processes used by government drug plans in Canada adhere to good governance principles?

Rawson NS, Adams J

ClinicoEconomics and Outcomes Research 2017, 9:721-730

Published Date: 22 November 2017

Original Research

Estimating the risk of severe hypoglycemic event related to glucose-lowering treatment among Italian patients with diabetes: the HYPOTHESIS database

Mazzi S, Ravasio R, Forlani G, Veronese G, Fabbri A, Marchesini G

ClinicoEconomics and Outcomes Research 2017, 9:711-720

Published Date: 21 November 2017

Original Research

Cost-consequence analysis of sitagliptin versus sulfonylureas as add-on therapy for the treatment of diabetic patients in Italy

Lorenzoni V, Baccetti F, Genovese S, Torre E, Turchetti G

ClinicoEconomics and Outcomes Research 2017, 9:699-710

Published Date: 20 November 2017

Original Research

Propofol or benzodiazepines for short- and long-term sedation in intensive care units? An economic evaluation based on meta-analytic results

Pradelli L, Povero M, Bürkle H, Kampmeier T, Della-Rocca G, Feuersenger A, Baron J, Westphal M

ClinicoEconomics and Outcomes Research 2017, 9:685-698

Published Date: 9 November 2017

Original Research

A comparative analysis of clinical outcomes and disposable costs of different catheter ablation methods for the treatment of atrioventricular nodal reentrant tachycardia

Berman AE, Rivner H, Chalkley R, Heboyan V

ClinicoEconomics and Outcomes Research 2017, 9:677-683

Published Date: 6 November 2017

Original Research

Repeated intermittent ulipristal acetate in the treatment of uterine fibroids: a cost-effectiveness analysis

Geale K, Saridogan E, Lehmann M, Arriagada P, Hultberg M, Henriksson M

ClinicoEconomics and Outcomes Research 2017, 9:669-676

Published Date: 1 November 2017

Original Research

Evaluating the cost-effectiveness of afatinib after platinum-based therapy for the treatment of squamous non-small-cell lung cancer in France

Pignata M, Chouaid C, Le Lay K, Luciani L, McConnachie C, Gordon J, Roze S

ClinicoEconomics and Outcomes Research 2017, 9:655-668

Published Date: 25 October 2017

Corrigendum

Burden of uterine fibroids in Italy: epidemiology, treatment outcomes, and consumption of health care resources in more than 5,000 women [Corrigendum]

Chiumente M, De Rosa M, Messori A, Proli EM

ClinicoEconomics and Outcomes Research 2017, 9:653-654

Published Date: 17 October 2017

Original Research

Cost-effectiveness of vedolizumab compared with conventional therapy for ulcerative colitis patients in the UK

Wilson MR, Azzabi Zouraq I, Chevrou-Severac H, Selby R, Kerrigan MC

ClinicoEconomics and Outcomes Research 2017, 9:641-652

Published Date: 16 October 2017

Original Research

Predictors of reaching a serum uric acid goal in patients with gout and treated with febuxostat

Sheer R, Null KD, Szymanski KA, Sudharshan L, Banovic J, Pasquale MK

ClinicoEconomics and Outcomes Research 2017, 9:629-639

Published Date: 10 October 2017

Original Research

Setting priorities in the health care sector – the case of oral anticoagulants in nonvalvular atrial fibrillation in Denmark

Poulsen PB, Johnsen SP, Hansen ML, Brandes A, Husted S, Harboe L, Dybro L

ClinicoEconomics and Outcomes Research 2017, 9:617-627

Published Date: 10 October 2017

Original Research

Epidemiology, patient profile, and health care resource use for hepatitis C in Italy

Sangiorgi D, Perrone V, Buda S, Boglione L, Cariti G, Lefevre C, Nappi C, Degli Esposti L

ClinicoEconomics and Outcomes Research 2017, 9:609-616

Published Date: 10 October 2017

Original Research

The cost of successful antiviral therapy in hepatitis C patients: a comparison of IFN-free versus IFN-based regimens at an individual patient level in Australia

Lee AS, van Driel ML, Crawford DHG

ClinicoEconomics and Outcomes Research 2017, 9:595-607

Published Date: 3 October 2017

Original Research

Utilization of fetal fibronectin testing and pregnancy outcomes among women with symptoms of preterm labor

Blackwell SC, Sullivan EM, Petrilla AA, Shen X, Troeger KA, Byrne JD

ClinicoEconomics and Outcomes Research 2017, 9:585-594

Published Date: 3 October 2017

Review

Drug tendering: drug supply and shortage implications for the uptake of biosimilars

Dranitsaris G, Jacobs I, Kirchhoff C, Popovian R, Shane LG

ClinicoEconomics and Outcomes Research 2017, 9:573-584

Published Date: 29 September 2017

Research Letter

Update of the budget impact analysis of the simplification to atazanavir + ritonavir + lamivudine dual therapy of HIV-positive patients receiving atazanavir-based triple therapies in Italy starting from data of the Atlas-M trial

Restelli U, Fabbiani M, Di Giambenedetto S, Nappi C, Croce D

ClinicoEconomics and Outcomes Research 2017, 9:569-571

Published Date: 27 September 2017

Original Research

Cost-effectiveness analysis of intravenous ferumoxytol for the treatment of iron deficiency anemia in adult patients with non-dialysis-dependent chronic kidney disease in the USA

Dahl NV, Kaper RF, Strauss WE, Corvino FA, Zivkovic M

ClinicoEconomics and Outcomes Research 2017, 9:557-567

Published Date: 20 September 2017

Original Research

Parenteral nutrition including an omega-3 fatty-acid-containing lipid emulsion for intensive care patients in China: a pharmacoeconomic analysis

Feng Y, Li C, Zhang T, Pradelli L

ClinicoEconomics and Outcomes Research 2017, 9:547-555

Published Date: 5 September 2017

Review

Current recommendations on the estimation of transition probabilities in Markov cohort models for use in health care decision-making: a targeted literature review

Olariu E, Cadwell KK, Hancock E, Trueman D, Chevrou-Severac H

ClinicoEconomics and Outcomes Research 2017, 9:537-546

Published Date: 1 September 2017

Original Research

Burden of uterine fibroids in Italy: epidemiology, treatment outcomes, and consumption of health care resources in more than 5,000 women

Chiumente M, De Rosa M, Messori A, Proli EM

ClinicoEconomics and Outcomes Research 2017, 9:525-535

Published Date: 29 August 2017

Original Research

Technology that achieves the Triple Aim: an economic analysis of the BrainPathTM approach in neurosurgery

Norton SP, Dickerson EM, Kulwin CG, Shah MV

ClinicoEconomics and Outcomes Research 2017, 9:519-523

Published Date: 26 August 2017

Original Research

A cost-effectiveness analysis of first-line induction and maintenance treatment sequences in patients with advanced nonsquamous non-small-cell lung cancer in France

Taipale K, Winfree KB, Boye M, Basson M, Sleilaty G, Eaton J, Evans R, Chouaid C

ClinicoEconomics and Outcomes Research 2017, 9:505-518

Published Date: 16 August 2017

Original Research

Budget impact of somatostatin analogs as treatment for metastatic gastroenteropancreatic neuroendocrine tumors in US hospitals

Ortendahl JD, Pulgar SJ, Mirakhur B, Cox D, Bentley TGK, Phan AT

ClinicoEconomics and Outcomes Research 2017, 9:495-503

Published Date: 16 August 2017

Original Research

Economic analysis and budget impact of clostridial collagenase ointment compared with medicinal honey for treatment of pressure ulcers in the US

Mearns ES, Liang M, Limone BL, Gilligan AM, Miller JD, Schaum KD, Waycaster CR

ClinicoEconomics and Outcomes Research 2017, 9:485-494

Published Date: 16 August 2017

Original Research

A budget impact analysis of parenteral iron treatments for iron deficiency anemia in the UK: reduced resource utilization with iron isomaltoside 1000

Pollock RF, Muduma G

ClinicoEconomics and Outcomes Research 2017, 9:475-483

Published Date: 10 August 2017

Review

The value of corneoscleral rim cultures in keratoplasty: a systematic review and cost-effectiveness analysis

Kiatos E, Armstrong JJ, Hutnik CML, Tsioros SM, Malvankar-Mehta MS, Hodge WG

ClinicoEconomics and Outcomes Research 2017, 9:459-474

Published Date: 9 August 2017

Original Research

Clinical and economic analysis of outcomes of dose tapering or withdrawal of tumor necrosis factor-α inhibitors upon achieving stable disease activity in rheumatoid arthritis patients

Aletaha D, Snedecor SJ, Ektare V, Xue M, Bao Y, Garg V

ClinicoEconomics and Outcomes Research 2017, 9:451-458

Published Date: 28 July 2017

Original Research

Cost analysis of adverse events associated with non-small cell lung cancer management in France

Chouaid C, Loirat D, Clay E, Millier A, Godard C, Fannan A, Lévy-Bachelot L, Angevin E

ClinicoEconomics and Outcomes Research 2017, 9:443-449

Published Date: 27 July 2017

Original Research

Cost of illness of urothelial bladder cancer in Italy

Gerace C, Montorsi F, Tambaro R, Cartenì G, De Luca S, Tucci M, Martorana G, Basso U, Cardosi L, Teruzzi C

ClinicoEconomics and Outcomes Research 2017, 9:433-442

Published Date: 24 July 2017

Original Research

Social and economic burden of patients with influenza-like illness and clinically diagnosed flu treated at various health facilities in Vietnam

Quang Vo T, Chaikledkaew U, Van Hoang M, Riewpaiboon A

ClinicoEconomics and Outcomes Research 2017, 9:423-432

Published Date: 19 July 2017

Original Research

The cost utility and budget impact of adjuvant racecadotril for acute diarrhea in children in Thailand

Rautenberg TA, Zerwes U

ClinicoEconomics and Outcomes Research 2017, 9:411-422

Published Date: 17 July 2017

Original Research

Mean cost per number needed to treat with tocilizumab plus methotrexate versus abatacept plus methotrexate in the treatment of rheumatoid arthritis in patients previously treated with methotrexate

Benucci M, Ravasio R, Damiani A

ClinicoEconomics and Outcomes Research 2017, 9:403-410

Published Date: 14 July 2017

Original Research

Subgroup analysis of telehealthcare for patients with chronic obstructive pulmonary disease: the cluster-randomized Danish Telecare North Trial

Witt Udsen F, Lilholt PH, Hejlesen OK, Ehlers LH

ClinicoEconomics and Outcomes Research 2017, 9:391-401

Published Date: 7 July 2017

Original Research

A cost analysis of a broad-spectrum antibiotic therapy in the empirical treatment of health care-associated infections in cirrhotic patients

Lucidi C, Di Gregorio V, Ceccarelli G, Venditti M, Riggio O, Merli M

ClinicoEconomics and Outcomes Research 2017, 9:385-390

Published Date: 29 June 2017

Original Research

Burden of air leak complications in thoracic surgery estimated using a national hospital billing database

Yoo A, Ghosh SK, Danker W, Kassis E, Kalsekar I

ClinicoEconomics and Outcomes Research 2017, 9:373-383

Published Date: 29 June 2017

Original Research

The economic and humanistic costs of chronic lower back pain in Japan

Montgomery W, Sato M, Nagasaka Y, Vietri J

ClinicoEconomics and Outcomes Research 2017, 9:361-371

Published Date: 23 June 2017

Original Research

Community-based health insurance and communities' scheme requirement compliance in Thehuldere district, northeast Ethiopia: cross-sectional community-based study

Workneh SG, Biks GA, Woreta SA

ClinicoEconomics and Outcomes Research 2017, 9:353-359

Published Date: 14 June 2017

Original Research

Economic and organizational sustainability of a negative-pressure portable device for the prevention of surgical-site complications

Foglia E, Ferrario L, Garagiola E, Signoriello G, Pellino G, Croce D, Canonico S

ClinicoEconomics and Outcomes Research 2017, 9:343-351

Published Date: 12 June 2017

Review

Oncology drugs for orphan indications: how are HTA processes evolving for this specific drug category?

Adkins EM, Nicholson L, Floyd D, Ratcliffe M, Chevrou-Severac H

ClinicoEconomics and Outcomes Research 2017, 9:327-342

Published Date: 10 June 2017

Original Research

Severe forms of fibromyalgia with acute exacerbation of pain: costs, comorbidities, and length of stay in inpatient care

Romeyke T, Noehammer E, Scheuer HC, Stummer H

ClinicoEconomics and Outcomes Research 2017, 9:317-325

Published Date: 1 June 2017

Original Research

In-center hemodialysis absenteeism: prevalence and association with outcomes

Gray KS, Cohen DE, Brunelli SM

ClinicoEconomics and Outcomes Research 2017, 9:307-315

Published Date: 24 May 2017

Original Research

Evaluation of the treatment patterns and economic burden of dysmenorrhea in Japanese women, using a claims database

Akiyama S, Tanaka E, Cristeau O, Onishi Y, Osuga Y

ClinicoEconomics and Outcomes Research 2017, 9:295-306

Published Date: 22 May 2017

Original Research

Cost per care of the first year of direct antiviral agents in the Liguria Region: a multicenter analysis

Cenderello G, Fanizza C, Marenco S, Nicolini LA, Artioli S, Baldissarro I, Dentone C, De Leo P, Di Biagio A

ClinicoEconomics and Outcomes Research 2017, 9:281-293

Published Date: 22 May 2017

Original Research

Medical resource utilization in dermatomyositis/polymyositis patients treated with repository corticotropin injection, intravenous immunoglobulin, and/or rituximab

Knight T, Bond TC, Popelar B, Wang L, Niewoehner JW, Anastassopoulos K, Philbin M

ClinicoEconomics and Outcomes Research 2017, 9:271-279

Published Date: 16 May 2017

Original Research

A retrospective analysis of delays in the diagnosis of lung cancer and associated costs

Gildea TR, DaCosta Byfield S, Hogarth DK, Wilson DS, Quinn CC

ClinicoEconomics and Outcomes Research 2017, 9:261-269

Published Date: 12 May 2017

Original Research

Adherence to disease-modifying therapies and its impact on relapse, health resource utilization, and costs among patients with multiple sclerosis

Burks J, Marshall TS, Ye X

ClinicoEconomics and Outcomes Research 2017, 9:251-260

Published Date: 28 April 2017

Original Research

Gastroenterologist and nurse management of symptoms after pelvic radiotherapy for cancer: an economic evaluation of a clinical randomized controlled trial (the ORBIT study)

Jordan J, Gage H, Benton B, Lalji A, Norton C, Andreyev HJN

ClinicoEconomics and Outcomes Research 2017, 9:241-249

Published Date: 28 April 2017

Original Research

Healthcare resource consumption and cost of care among patients with polycystic kidney disease in Italy

Degli Esposti L, Veronesi C, Perrone V, Buda S, Santoro A

ClinicoEconomics and Outcomes Research 2017, 9:233-239

Published Date: 27 April 2017

Corrigendum

Budget impact analysis of the simplification to atazanavir + ritonavir + lamivudine dual therapy of HIV-positive patients receiving atazanavir-based triple therapies in Italy starting from data of the Atlas-M trial [Corrigendum]

Restelli U, Fabbiani M, Di Giambenedetto S, Nappi C, Croce D

ClinicoEconomics and Outcomes Research 2017, 9:231-232

Published Date: 19 April 2017

Original Research

Cost-effectiveness analysis of abobotulinumtoxinA for the treatment of cervical dystonia in the United Kingdom

Muthukumar M, Desai K, Abogunrin S, Harrower T, Gabriel S, Dinet J

ClinicoEconomics and Outcomes Research 2017, 9:211-229

Published Date: 15 April 2017

Original Research

Economic benefit of back titration in the treatment of hypertension in Jos, Nigeria

Okeahialam BN, Adeniyi MA

ClinicoEconomics and Outcomes Research 2017, 9:207-210

Published Date: 10 April 2017

Original Research

Cost analysis of pulmonary lobectomy procedure: comparison of stapler versus precision dissection and sealant

Droghetti A, Marulli G, Vannucci J, Giovanardi M, Bottoli MC, Ragusa M, Muriana G

ClinicoEconomics and Outcomes Research 2017, 9:201-206

Published Date: 3 April 2017

Original Research

Survey on attitudes of Italian pediatricians toward cough

Zanasi A, Morcaldi L, Cazzato S, Mazzolini M, Lecchi M, Morselli-Labate AM, Mastroroberto M, Dal Negro RW

ClinicoEconomics and Outcomes Research 2017, 9:189-199

Published Date: 16 March 2017

Original Research

Topical medication utilization and health resources consumption in adult patients affected by psoriasis: findings from the analysis of administrative databases of local health units

Perrone V, Sangiorgi D, Buda S, Degli Esposti L

ClinicoEconomics and Outcomes Research 2017, 9:181-188

Published Date: 6 March 2017

Original Research

Budget impact analysis of the simplification to atazanavir + ritonavir + lamivudine dual therapy of HIV-positive patients receiving atazanavir-based triple therapies in Italy starting from data of the Atlas-M trial

Restelli U, Fabbiani M, Di Giambenedetto S, Nappi C, Croce D

ClinicoEconomics and Outcomes Research 2017, 9:173-179

Published Date: 1 March 2017

Original Research

Optimizing choice of oral interferon-free treatment for genotype 1 hepatitis C virus using testing for NS5A resistance: a cost-utility analysis from the perspective of the Italian National Health Service

Westerhout KY, Bouwmeester W, Duchesne I, Pisini M, Piena MA, Damele F, Gueron B, Treur M, Belsey J

ClinicoEconomics and Outcomes Research 2017, 9:163-172

Published Date: 27 February 2017

Review

Home hemodialysis: a comprehensive review of patient-centered and economic considerations

Walker RC, Howard K, Morton RL

ClinicoEconomics and Outcomes Research 2017, 9:149-161

Published Date: 16 February 2017

Original Research

Determinants of biological drug survival in rheumatoid arthritis: evidence from a Hungarian rheumatology center over 8 years of retrospective data

Brodszky V, Bíró A, Szekanecz Z, Soós B, Baji P, Rencz F, Tóthfalusi L, Gulácsi L, Péntek M

ClinicoEconomics and Outcomes Research 2017, 9:139-147

Published Date: 15 February 2017

Original Research

Estimating the economic consequences of an increased medication adherence due to a potential improvement in the inhaler technique with Spiromax® compared with Turbuhaler® in patients with moderate-to-severe chronic obstructive pulmonary disease in Spain

Darbà J, Ramírez G, García-Rivero JL, Mayoralas S, Pascual JF, Vargas D, Bijedic A

ClinicoEconomics and Outcomes Research 2017, 9:127-137

Published Date: 10 February 2017

Original Research

Time and resources of peripherally inserted central catheter insertion procedures: a comparison between blind insertion/chest X-ray and a real time tip navigation and confirmation system

Tomaszewski KJ, Ferko N, Hollmann SS, Eng SC, Richard HM, Rowe L, Sproule S

ClinicoEconomics and Outcomes Research 2017, 9:115-125

Published Date: 7 February 2017

Original Research

Cost analysis of facial injury treatment in two university hospitals in Malaysia: a prospective study

Saperi BS, Ramli R, Ahmed Z, Muhd Nur A, Ibrahim MI, Rashdi MF, Nordin R, Rahman NA, Yusoff A, Nazimi AJ, Abdul Rahman R, Abdul Razak N, Mohamed N

ClinicoEconomics and Outcomes Research 2017, 9:107-113

Published Date: 7 February 2017

Original Research

The cost-effectiveness of a NSCLC patient assistance program for pemetrexed maintenance therapy in People's Republic of China

Shi Q, Hu S, Furnback WE, Guzauskas GF, Shen J, Wang BCM

ClinicoEconomics and Outcomes Research 2017, 9:99-106

Published Date: 3 February 2017

Original Research

Health care resource utilization before and after natalizumab initiation among patients with multiple sclerosis in Germany

Watson C, Prosser C, Braun S, Landsman-Blumberg PB, Gleissner E, Naoshy S

ClinicoEconomics and Outcomes Research 2017, 9:85-97

Published Date: 1 February 2017

Original Research

Cost-effectiveness of SQ® HDM SLIT-tablet in addition to pharmacotherapy for the treatment of house dust mite allergic rhinitis in Germany

Green W, Kleine-Tebbe J, Klimek L, Hahn-Pedersen J, Nørgaard Andreasen J, Taylor M

ClinicoEconomics and Outcomes Research 2017, 9:77-84

Published Date: 16 February 2017

Corrigendum

Potential resource and cost saving analysis of subcutaneous versus intravenous administration for rituximab in non-Hodgkin’s lymphoma and for trastuzumab in breast cancer in 17 Italian hospitals based on a systematic survey [Corrigendum]

Ponzetti C, Canciani M, Farina M, Era S, Walzer S

ClinicoEconomics and Outcomes Research 2017, 9:75-76

Published Date: 17 January 2017

Original Research

Dalteparin versus vitamin K antagonists for the prevention of recurrent venous thromboembolism in patients with cancer and renal impairment: a Canadian pharmacoeconomic analysis

Dranitsaris G, Shane LG, Crowther M, Feugere G, Woodruff S

ClinicoEconomics and Outcomes Research 2017, 9:65-73

Published Date: 10 January 2017

Original Research

Improving outpatient primary medication adherence with physician guided, automated dispensing

Moroshek JG

ClinicoEconomics and Outcomes Research 2017, 9:59-63

Published Date: 5 January 2017

Original Research

Relative cost-effectiveness of using a liquid human milk fortifier in preterm infants in the US

Guest JF, Moya F, Sisk PM, Hudak ML, Kuehn D

ClinicoEconomics and Outcomes Research 2017, 9:49-57

Published Date: 4 January 2017

Original Research

Cost-effectiveness analysis of combination antifungal therapy with voriconazole and anidulafungin versus voriconazole monotherapy for primary treatment of invasive aspergillosis in Spain

Grau S, Azanza JR, Ruiz I, Vallejo C, Mensa J, Maertens J, Heinz WJ, Barrueta JA, Peral C, Mesa FJ, Barrado M, Charbonneau C, Rubio-Rodríguez D, Rubio-Terrés C

ClinicoEconomics and Outcomes Research 2017, 9:39-47

Published Date: 30 December 2016

Original Research

Costs of adverse events associated with erlotinib or afatinib in first-line treatment of advanced EGFR-positive non-small cell lung cancer

Isla D, De Castro J, Juan O, Grau S, Orofino J, Gordo R, Rubio-Terrés C, Rubio-Rodríguez D

ClinicoEconomics and Outcomes Research 2017, 9:31-38

Published Date: 30 December 2016

Original Research

Real-world medication persistence and outcomes associated with basal insulin and glucagon-like peptide 1 receptor agonist free-dose combination therapy in patients with type 2 diabetes in the US

Lin J, Lingohr-Smith M, Fan T

ClinicoEconomics and Outcomes Research 2017, 9:19-29

Published Date: 22 December 2016

Original Research

Persistence, switch rates, drug consumption and costs of biological treatment of rheumatoid arthritis: an observational study in Italy

Degli Esposti L, Favalli EG, Sangiorgi D, Di Turi R, Farina G, Gambera M, Ravasio R

ClinicoEconomics and Outcomes Research 2017, 9:9-17

Published Date: 21 December 2016

Original Research

Economic report on the cost of dengue fever in Vietnam: case of a provincial hospital

Pham LD, Phung NHT, Le NTD, Vo TQ

ClinicoEconomics and Outcomes Research 2017, 9:1-8

Published Date: 16 December 2016

Original Research

Treatment effectiveness and treatment patterns among rheumatoid arthritis patients after switching from a tumor necrosis factor inhibitor to another medication

Bonafede MMK, Curtis JR, McMorrow D, Mahajan P, Chen C

ClinicoEconomics and Outcomes Research 2016, 8:707-715

Published Date: 2 December 2016

Original Research

Prioritizing health system and disease burden factors: an evaluation of the net benefit of transferring health technology interventions to different districts in Zimbabwe

Shamu S, Rusakaniko S, Hongoro C

ClinicoEconomics and Outcomes Research 2016, 8:695-705

Published Date: 24 November 2016

Original Research

Patient-reported financial barriers to adherence to treatment in neurology

Moura LMVR, Schwamm EL, Moura Junior V, Seitz MP, Hoch DB, Hsu J, Schwamm LH

ClinicoEconomics and Outcomes Research 2016, 8:685-694

Published Date: 17 November 2016

Original Research

Evaluating increased resource use in fibromyalgia using electronic health records

Margolis JM, Masters ET, Cappelleri JC, Smith DM, Faulkner S

ClinicoEconomics and Outcomes Research 2016, 8:675-683

Published Date: 16 November 2016

Original Research

UK-specific cost-effectiveness of tiotropium + olodaterol fixed-dose combination versus other LAMA + LABA combinations in patients with COPD

Tebboth A, Ternouth A, Gonzalez-Rojas N

ClinicoEconomics and Outcomes Research 2016, 8:667-674

Published Date: 7 November 2016

Original Research

Economic impact of longer battery life of cardiac resynchronization therapy defibrillators in Sweden

Gadler F, Ding Y, Verin N, Bergius M, Miller JD, Lenhart GM, Russell MW

ClinicoEconomics and Outcomes Research 2016, 8:657-666

Published Date: 31 October 2016

Original Research

Residual cardiovascular risk in patients who received lipid-lowering treatment in a real-life setting: retrospective study

Perrone V, Sangiorgi D, Buda S, Degli Esposti L

ClinicoEconomics and Outcomes Research 2016, 8:649-655

Published Date: 25 October 2016

Original Research

Health care resource use and costs associated with possible side effects of high oral corticosteroid use in asthma: a claims-based analysis

Luskin AT, Antonova EN, Broder MS, Chang EY, Omachi TA, Ledford DK

ClinicoEconomics and Outcomes Research 2016, 8:641-648

Published Date: 25 October 2016

Original Research

Relative cost-effectiveness of using an extensively hydrolyzed casein formula in managing infants with cow’s milk allergy in Brazil

Guest JF, Yang AC, Oba J, Rodrigues M, Caetano R, Polster L

ClinicoEconomics and Outcomes Research 2016, 8:629-639

Published Date: 19 October 2016

Original Research

The direct health-care burden of valvular heart disease: evidence from US national survey data

Moore M, Chen J, Mallow PJ, Rizzo JA

ClinicoEconomics and Outcomes Research 2016, 8:613-627

Published Date: 18 October 2016

Review

Bringing patient centricity to diabetes medication access in Canada

Glennie JL, Kovacs Burns K, Oh P

ClinicoEconomics and Outcomes Research 2016, 8:599-611

Published Date: 17 October 2016

Original Research

Disease progression and health care resource consumption in patients affected by hepatitis C virus in real practice setting

Perrone V, Sangiorgi D, Buda S, Degli Esposti L

ClinicoEconomics and Outcomes Research 2016, 8:591-597

Published Date: 14 October 2016

Original Research

Cost-effectiveness of eplerenone in NYHA class II chronic heart failure patients with reduced LVEF: an analysis for Greece

Athanasakis K, Bilitou A, Lee D, Karampli E, Karavidas A, Parissis J, Sykara G, Kyriopoulos J

ClinicoEconomics and Outcomes Research 2016, 8:583-590

Published Date: 12 October 2016

Original Research

Methods to construct a step-by-step beginner’s guide to decision analytic cost-effectiveness modeling

Rautenberg T, Hulme C, Edlin R

ClinicoEconomics and Outcomes Research 2016, 8:573-581

Published Date: 11 October 2016

Review

Evaluating health-related quality of life in type 1 diabetes: a systematic literature review of utilities for adults with type 1 diabetes

Smith-Palmer J, Bae JP, Boye KS, Norrbacka K, Hunt B, Valentine WJ

ClinicoEconomics and Outcomes Research 2016, 8:559-571

Published Date: 7 October 2016

Review

Health and economic benefits of physical activity for patients with spinal cord injury

Miller LE, Herbert WG

ClinicoEconomics and Outcomes Research 2016, 8:551-558

Published Date: 3 October 2016

Original Research

Cost-effectiveness analysis of fesoterodine flexible dose in newly diagnosed patients with overactive bladder in routine clinical practice in Spain

Peral C, Sánchez-Ballester F, García-Mediero JM, Ramos J, Rejas J

ClinicoEconomics and Outcomes Research 2016, 8:541-550

Published Date: 26 September 2016

Original Research

Cost-effectiveness analysis of online hemodiafiltration versus high-flux hemodialysis

Ramponi F, Ronco C, Mason G, Rettore E, Marcelli D, Martino F, Neri M, Martin-Malo A, Canaud B, Locatelli F

ClinicoEconomics and Outcomes Research 2016, 8:531-540

Published Date: 22 September 2016

Original Research

Cost-effectiveness of dipeptidyl peptidase-4 inhibitor monotherapy in elderly type 2 diabetes patients in Thailand

Permsuwan U, Dilokthornsakul P, Saokaew S, Thavorn K, Chaiyakunapruk N

ClinicoEconomics and Outcomes Research 2016, 8:521-529

Published Date: 21 September 2016

Original Research

A hospital cost analysis of a fibrin sealant patch in soft tissue and hepatic surgical bleeding

Corral M, Ferko N, Hogan A, Hollmann SS, Gangoli G, Jamous N, Batiller J, Kocharian R

ClinicoEconomics and Outcomes Research 2016, 8:507-519

Published Date: 21 September 2016

Review

Patient-level costs of major cardiovascular conditions: a review of the international literature

Nicholson G, Gandra SR, Halbert RJ, Richhariya A, Nordyke RJ

ClinicoEconomics and Outcomes Research 2016, 8:495-506

Published Date: 21 September 2016

Original Research

Economic evaluation of eribulin as second-line treatment for metastatic breast cancer in South Korea

Tremblay G, Majethia U, Breeze JL, Kontoudis I, Park J

ClinicoEconomics and Outcomes Research 2016, 8:485-493

Published Date: 19 September 2016

Original Research

Economic evaluation of obinutuzumab in combination with chlorambucil in first-line treatment of patients with chronic lymphocytic leukemia in Spain

Casado LF, Burgos A, González-Haba E, Loscertales J, Krivasi T, Orofino J, Rubio-Terres C, Rubio-Rodríguez D

ClinicoEconomics and Outcomes Research 2016, 8:475-484

Published Date: 21 September 2016

Original Research

Consequences of inaccurate hepatitis C virus genotyping on the costs of prescription of direct antiviral agents in an Italian district

Polilli E, Cento V, Restelli U, Ceccherini-Silberstein F, Aragri M, Di Maio VC, Sciacca A, Santoleri F, Fazii P, Costantini A, Perno CF, Parruti G

ClinicoEconomics and Outcomes Research 2016, 8:467-473

Published Date: 14 September 2016

Original Research

Cost analysis of magnetically controlled growing rods compared with traditional growing rods for early-onset scoliosis in the US: an integrated health care delivery system perspective

Polly Jr DW, Ackerman SJ, Schneider K, Pawelek JB, Akbarnia BA

ClinicoEconomics and Outcomes Research 2016, 8:457-465

Published Date: 14 September 2016

Original Research

Cost versus utility of aclidinium bromide 400 μg plus formoterol fumarate dihydrate 12 μg compared to aclidinium bromide 400 μg alone in the management of moderate-to-severe COPD

Ramos M, Haughney J, Henry N, Lindner L, Lamotte M

ClinicoEconomics and Outcomes Research 2016, 8:445-456

Published Date: 12 September 2016

Original Research

A budget impact analysis of Spiromax® compared with Turbuhaler® for the treatment of moderate to severe asthma: a potential improvement in the inhalation technique to strengthen medication adherence could represent savings for the Spanish Healthcare System and five Spanish regions

Darbà J, Ramírez G, García-Rivero JL, Mayoralas-Alises S, Pascual JF, Roger A,Vargas D, Bijedic A

ClinicoEconomics and Outcomes Research 2016, 8:435-444

Published Date: 6 September 2016

Original Research

Targeting improved patient outcomes using innovative product listing agreements: a survey of Canadian and international key opinion leaders

Thompson M, Henshall C, Garrison LP, Griffin AD, Coyle D, Long S, Khayat ZA, Anger DL, Yu R

ClinicoEconomics and Outcomes Research 2016, 8:427-433

Published Date: 26 August 2016

Review

A systematic review of observational studies evaluating costs of adverse drug reactions

Batel Marques F, Penedones A, Mendes D, Alves C

ClinicoEconomics and Outcomes Research 2016, 8:413-426

Published Date: 24 August 2016

Original Research

Impact of hospitalizations for bronchiolitis in preterm infants on long-term health care costs in Italy: a retrospective case-control study

Roggeri DP, Roggeri A, Rossi E, Cataudella S, Martini N

ClinicoEconomics and Outcomes Research 2016, 8:407-412

Published Date: 4 August 2016

Original Research

Cost-effectiveness of primary debulking surgery when compared to neoadjuvant chemotherapy in the management of stage III C and IV epithelial ovarian cancer

Forde GK, Chang J, Ziogas A

ClinicoEconomics and Outcomes Research 2016, 8:397-406

Published Date: 2 August 2016

Original Research

The epidemiology and burden of Alzheimer’s disease in Taiwan utilizing data from the National Health Insurance Research Database

Hung YN, Kadziola Z, Brnabic AJM, Yeh JF, Fuh JL, Hwang JP, Montgomery W

ClinicoEconomics and Outcomes Research 2016, 8:387-395

Published Date: 2 August 2016

Original Research

Financial and feasibility implications of the treatment of hepatitis C virus in Italy: scenarios and perspectives

Croce D, Bonfanti M, Restelli U

ClinicoEconomics and Outcomes Research 2016, 8:377-385

Published Date: 8 August 2016

Original Research

Work intensity in sacroiliac joint fusion and lumbar microdiscectomy

Frank C, Kondrashov D, Meyer SC, Dix G, Lorio M, Kovalsky D, Cher D

ClinicoEconomics and Outcomes Research 2016, 8:367-376

Published Date: 26 July 2016

Original Research

Characterizing individual painDETECT symptoms by average pain severity

Sadosky A, Koduru V, Bienen EJ, Cappelleri JC

ClinicoEconomics and Outcomes Research 2016, 8:361-366

Published Date: 26 July 2016

Original Research

Administrative risk quantification of subcutaneous and intravenous therapies in Italian centers utilizing the Failure Mode and Effects Analysis approach

Ponzetti C, Canciani M, Farina M, Era S, Walzer S

ClinicoEconomics and Outcomes Research 2016, 8:353-359

Published Date: 3 August 2016

Erratum

Prolonged length of stay associated with air leak following pulmonary resection has a negative impact on hospital margin [Erratum]

Wood DE, Lauer LM, Layton A, Tong KB

ClinicoEconomics and Outcomes Research 2016, 8:351-352

Published Date: 15 July 2016

Corrigendum

Ignoring the sacroiliac joint in chronic low back pain is costly [Corrigendum]

Polly DW, Cher D

ClinicoEconomics and Outcomes Research 2016, 8:349-350

Published Date: 8 July 2016

Review

Screening strategies for active tuberculosis: focus on cost-effectiveness

Dobler CC

ClinicoEconomics and Outcomes Research 2016, 8:335-347

Published Date: 30 June 2016

Methodology

Determination of the most appropriate method for extrapolating overall survival data from a placebo-controlled clinical trial of lenvatinib for progressive, radioiodine-refractory differentiated thyroid cancer

Tremblay G, Livings C, Crowe L, Kapetanakis V, Briggs A

ClinicoEconomics and Outcomes Research 2016, 8:323-333

Published Date: 30 June 2016

Original Research

The use of sugammadex for bariatric surgery: analysis of recovery time from neuromuscular blockade and possible economic impact

De Robertis E, Zito Marinosci G, Romano GM, Piazza O, Iannuzzi M, Cirillo F, De Simone S, Servillo G

ClinicoEconomics and Outcomes Research 2016, 8:317-322

Published Date: 29 June 2016

Original Research

Relative cost-effectiveness of using an extensively hydrolyzed casein formula containing the probiotic Lactobacillus rhamnosus GG in managing infants with cow's milk allergy in Poland

Guest JF, Weidlich D, Kaczmarski M, Jarocka-Cyrta E, Kobelska-Dubiel N, Krauze A, Sakowska-Maliszewska I, Zawadzka-Krajewska A

ClinicoEconomics and Outcomes Research 2016, 8:307-316

Published Date: 28 June 2016

Corrigendum

Cost-effectiveness of minimally invasive sacroiliac joint fusion [Corrigendum]

Cher DJ, Frasco MA, Arnold RJG, Polly DW

ClinicoEconomics and Outcomes Research 2016, 8:305-306

Published Date: 27 June 2016

Review

A structured review of health utility measures and elicitation in advanced/metastatic breast cancer

Hao Y, Wolfram V, Cook J

ClinicoEconomics and Outcomes Research 2016, 8:293-303

Published Date: 23 June 2016

Original Research

Is the routine use of bevacizumab in the treatment of women with advanced or recurrent cancer of the cervix sustainable?

Klag N, Walter AC, Sheely KM, Manahan KJ, Geisler JP

ClinicoEconomics and Outcomes Research 2016, 8:287-291

Published Date: 21 June 2016

Original Research

Economic analysis of empiric versus diagnostic-driven strategies for immunocompromised patients with suspected fungal infections in the People's Republic of China

Mao NY, Lesher B, Liu QF, Qin L, Chen YX, Gao X, Earnshaw SR, McDade CL, Charbonneau C

ClinicoEconomics and Outcomes Research 2016, 8:275-285

Published Date: 14 June 2016

Original Research

A comparison of EuroQol 5-Dimension health-related utilities using Italian, UK, and US preference weights in a patient sample

Mozzi A, Meregaglia M, Lazzaro C, Tornatore V, Belfiglio M, Fattore G

ClinicoEconomics and Outcomes Research 2016, 8:267-274

Published Date: 13 June 2016

Original Research

Scaling up health knowledge at European level requires sharing integrated data: an approach for collection of database specification

Menditto E, Bolufer de Gea A, Cahir C, Marengoni A, Riegler S, Fico G, Costa E, Monaco A, Pecorelli S, Pani L, Prados-Torres A

ClinicoEconomics and Outcomes Research 2016, 8:253-265

Published Date: 13 June 2016

Original Research

Cost-effectiveness of tiotropium versus glycopyrronium in moderate to very severe chronic obstructive pulmonary disease in Canada, Spain, Sweden, and the UK

Eklund O, Afzal F, Borgström F, Flavin J, Ternouth A, Ojanguren ME, Crespo C, Baldwin M

ClinicoEconomics and Outcomes Research 2016, 8:243-252

Published Date: 11 June 2016

Original Research

Savings associated with high-dose hypoallergenic house dust mite immunotherapy in rhinitis and/or asthma patients in Spain

García Robaina JC, Polanco Sánchez C, Estella Pérez E

ClinicoEconomics and Outcomes Research 2016, 8:235-241

Published Date: 14 June 2016

Original Research

Potential resource and cost saving analysis of subcutaneous versus intravenous administration for rituximab in non-Hodgkin's lymphoma and for trastuzumab in breast cancer in 17 Italian hospitals based on a systematic survey

Ponzetti C, Canciani M, Farina M, Era S, Walzer S

ClinicoEconomics and Outcomes Research 2016, 8:227-233

Published Date: 23 May 2016

Original Research

Cost-effectiveness of edoxaban versus rivaroxaban for stroke prevention in patients with nonvalvular atrial fibrillation (NVAF) in the US

Miller JD, Ye X, Lenhart GM, Farr AM, Tran OV, Kwong WJ, Magnuson EA, Weintraub WS

ClinicoEconomics and Outcomes Research 2016, 8:215-226

Published Date: 20 May 2016

Original Research

The changing landscape of antiviral treatment of herpes zoster: a 17-year population-based cohort study

Friesen KJ, Alessi-Severini S, Chateau D, Falk J, Bugden S

ClinicoEconomics and Outcomes Research 2016, 8:207-214

Published Date: 20 May 2016

Methodology

Estimated hospital costs associated with preventable health care-associated infections if health care antiseptic products were unavailable

Schmier JK, Hulme-Lowe CK, Semenova S, Klenk JA, DeLeo PC, Sedlak R, Carlson PA

ClinicoEconomics and Outcomes Research 2016, 8:197-205

Published Date: 13 May 2016

Original Research

Prolonged length of stay associated with air leak following pulmonary resection has a negative impact on hospital margin

Wood DE, Lauer LM, Layton A, Tong KB

ClinicoEconomics and Outcomes Research 2016, 8:187-195

Published Date: 17 May 2016

Original Research

Treatment patterns and health care resource utilization associated with dalfampridine extended release in multiple sclerosis: a retrospective claims database analysis

Guo A, Grabner M, Palli SR, Elder J, Sidovar M, Aupperle P, Krieger S

ClinicoEconomics and Outcomes Research 2016, 8:177-186

Published Date: 12 May 2016

Original Research

The economic impact of educational training assessed by the Handling Questionnaire with three inhalation devices in asthma and Chronic Obstructive Pulmonary Disease patients

Dal Negro RW, Povero M

ClinicoEconomics and Outcomes Research 2016, 8:171-176

Published Date: 10 May 2016

Original Research

Economic burden of refractory chronic spontaneous urticaria on Kuwait's health system

Al-Ahmad M, Alowayesh MS, Carroll NV

ClinicoEconomics and Outcomes Research 2016, 8:163-169

Published Date: 10 May 2016

Original Research

Difficult-to-heal wounds of mixed arterial/venous and venous etiology: a cost-effectiveness analysis of extracellular matrix

Romanelli M, Gilligan AM, Waycaster CR, Dini V

ClinicoEconomics and Outcomes Research 2016, 8:153-161

Published Date: 4 May 2016

Review

Cost-effectiveness of bortezomib for multiple myeloma: a systematic review

Chen W, Yang Y, Chen Y, Du F, Zhan H

ClinicoEconomics and Outcomes Research 2016, 8:137-151

Published Date: 3 May 2016

Original Research

Hospitalization and cost after switching from atypical to typical antipsychotics in schizophrenia patients in Thailand

Boonlue T, Subongkot S, Dilokthornsakul P, Kongsakon R, Pattanaprateep O, Suanchang O, Chaiyakunapruk N

ClinicoEconomics and Outcomes Research 2016, 8:127-136

Published Date: 29 April 2016

Original Research

A burden of illness study for neuropathic pain in Europe

Liedgens H, Obradovic M, De Courcy J, Holbrook T, Jakubanis R

ClinicoEconomics and Outcomes Research 2016, 8:113-126

Published Date: 27 April 2016

Original Research

Real-world hospital costs for nonchemotherapy drugs and nondrug care associated with platinum-based doublets in the first-line setting for advanced nonsquamous non-small-cell lung cancer in Chinese patients: a retrospective cohort study

Chen JH, Wu S, Hu C, Yang Y, Rajan N, Chen Y, Yang C, Li J, Chen W

ClinicoEconomics and Outcomes Research 2016, 8:97-111

Published Date: 26 April 2016

Original Research

Long-term outcomes in chronic obstructive pulmonary disease patients: exploring the effects of inhalatory devices and their influence on the outcome

Fadda V, Maratea D

ClinicoEconomics and Outcomes Research 2016, 8:87-95

Published Date: 15 April 2016

Original Research

Productivity benefits of minimally invasive surgery in patients with chronic sacroiliac joint dysfunction

Saavoss JD, Koenig L, Cher DJ

ClinicoEconomics and Outcomes Research 2016, 8:77-85

Published Date: 11 April 2016

Letter

Designing economic evaluations to facilitate optimal decisions: the need to avoid bias

Lee KM, Coyle K, Coyle D

ClinicoEconomics and Outcomes Research 2016, 8:73-76

Published Date: 5 April 2016

Review

Methicillin-resistant Staphylococcus aureus nosocomial pneumonia: role of linezolid in the People's Republic of China

Lesher B, Gao X, Chen Y, Liu Z

ClinicoEconomics and Outcomes Research 2016, 8:63-72

Published Date: 24 March 2016

Original Research

Short- and longer-term health-care resource utilization and costs associated with acute ischemic stroke

Johnson BH, Bonafede MM, Watson C

ClinicoEconomics and Outcomes Research 2016, 8:53-61

Published Date: 23 February 2016

Original Research

Sugammadex for reversal of neuromuscular blockade: a retrospective analysis of clinical outcomes and cost-effectiveness in a single center

Carron M, Baratto F, Zarantonello F, Ori C

ClinicoEconomics and Outcomes Research 2016, 8:43-52

Published Date: 18 February 2016

Review

Costs associated with rheumatoid arthritis in Italy: past, present, and future

Benucci M, Rogai V, Atzeni F, Hammen V, Sarzi-Puttini P, Migliore A

ClinicoEconomics and Outcomes Research 2016, 8:33-41

Published Date: 10 February 2016

Original Research

Ignoring the sacroiliac joint in chronic low back pain is costly

Polly DW, Cher D

ClinicoEconomics and Outcomes Research 2016, 8:23-31

Published Date: 21 January 2016

Original Research

Budget impact analysis of sofosbuvir-based regimens for the treatment of HIV/HCV-coinfected patients in northern Italy: a multicenter regional simulation

Cenderello G, Artioli S, Viscoli C, Pasa A, Giacomini M, Giannini B, Dentone C, Nicolini LA, Cassola G, Di Biagio A

ClinicoEconomics and Outcomes Research 2016, 8:15-21

Published Date: 31 December 2015

Original Research

Cost-effectiveness of minimally invasive sacroiliac joint fusion

Cher DJ, Frasco MA, Arnold RJG, Polly DW

ClinicoEconomics and Outcomes Research 2016, 8:1-14

Published Date: 18 December 2015

Original Research

The impact of ribavirin on real-world adherence rates in hepatitis C patients treated with sofosbuvir plus simeprevir

Walker DR, Juday TR, Manthena SR, Jing Y, Sood V

ClinicoEconomics and Outcomes Research 2015, 7:637-642

Published Date: 17 December 2015

Methodology

Adjustment of foreign EQ-5D-3L utilities can increase their transferability

Oddershede L, Petersen KD

ClinicoEconomics and Outcomes Research 2015, 7:629-636

Published Date: 15 December 2015

Original Research

Estimating health-state utility values for patients with recurrent ovarian cancer using Functional Assessment of Cancer Therapy – General mapping algorithms

Hettle R, Borrill J, Suri G, Wulff J

ClinicoEconomics and Outcomes Research 2015, 7:615-627

Published Date: 26 November 2015

Original Research

Gastrointestinal events and association with initiation of treatment for osteoporosis

Modi A, Siris ES, Tang J, Sajjan S, Sen SS

ClinicoEconomics and Outcomes Research 2015, 7:603-613

Published Date: 25 November 2015

Original Research

Productivity loss and resource utilization, and associated indirect and direct costs in individuals providing care for adults with schizophrenia in the EU5

Gupta S, Isherwood G, Jones K, Van Impe K

ClinicoEconomics and Outcomes Research 2015, 7:593-602

Published Date: 25 November 2015

Original Research

Relative cost-effectiveness of using an extensively hydrolyzed casein formula containing the probiotic Lactobacillus rhamnosus GG in managing infants with cow’s milk allergy in Spain

Guest JF, Weidlich D, Mascuñán Díaz JI, Díaz JJ, Ojeda PM, Ferrer-González JP, Gil D, Onrubia I, Rincón Víctor P

ClinicoEconomics and Outcomes Research 2015, 7:583-591

Published Date: 23 November 2015

Original Research

Doctors commitment and long-term effectiveness for cost containment policies: lesson learned from biosimilar drugs

Menditto E, Orlando V, Coretti S, Putignano D, Fiorentino D, Ruggeri M

ClinicoEconomics and Outcomes Research 2015, 7:575-581

Published Date: 11 November 2015

Original Research

Variation in hospital resource use and cost among surgical procedures using topical absorbable hemostats

Martyn D, Meckley LM, Miyasato G, Lim S, Riebman JB, Kocharian R, Scaife JG, Rao Y, Corral M

ClinicoEconomics and Outcomes Research 2015, 7:567-574

Published Date: 6 November 2015

Review

Impact of treatment with rosuvastatin and atorvastatin on cardiovascular outcomes: evidence from the Archimedes-simulated clinical trials

Colivicchi F, Sternhufvud C, Gandhi SK

ClinicoEconomics and Outcomes Research 2015, 7:555-565

Published Date: 27 November 2015

Original Research

The financial burden of sickle cell disease on households in Ekiti, Southwest Nigeria

Olatunya OS, Ogundare EO, Fadare JO, Oluwayemi IO, Agaja OT, Adeyefa BS, Aderiye O

ClinicoEconomics and Outcomes Research 2015, 7:545-553

Published Date: 4 November 2015

Original Research

The expenditures related to the use of antifungal drugs in patients with hematological cancers: a cost analysis

Gedik H

ClinicoEconomics and Outcomes Research 2015, 7:537-543

Published Date: 3 November 2015

Original Research

Cost-effectiveness of three echinocandins and fluconazole in the treatment of candidemia and/or invasive candidiasis in nonneutropenic adult patients

Grau S, Pozo JC, Romá E, Salavert M, Barrueta JA, Peral C, Rodriguez I, Rubio-Rodríguez D, Rubio-Terrés C

ClinicoEconomics and Outcomes Research 2015, 7:527-535

Published Date: 13 October 2015

Letter

Linezolid for the treatment of hospital-acquired pneumonia in a Chinese tertiary hospital

Lesher BA, Liu Z, Chen Y, Gao X

ClinicoEconomics and Outcomes Research 2015, 7:521-526

Published Date: 9 October 2015

Original Research

Cost-effectiveness analysis of pregabalin for treatment of chronic low back pain in patients with accompanying lower limb pain (neuropathic component) in Japan

Igarashi A, Akazawa M, Murata T, Taguchi T, Sadosky A, Ebata N, Willke R, Fujii K, Doherty J, Kobayashi M

ClinicoEconomics and Outcomes Research 2015, 7:505-520

Published Date: 7 October 2015

Original Research

Bias within economic evaluations – the impact of considering the future entry of lower-cost generics on currently estimated incremental cost-effectiveness ratios of a new drug

Guertin JR, Mitchell D, Ali F, LeLorier J

ClinicoEconomics and Outcomes Research 2015, 7:497-503

Published Date: 6 October 2015

Original Research

Annual impact of scribes on physician productivity and revenue in a cardiology clinic

Bank AJ, Gage RM

ClinicoEconomics and Outcomes Research 2015, 7:489-495

Published Date: 30 September 2015

Original Research

Estimating the health care burden of prescription opioid abuse in five European countries

Shei A, Hirst M, Kirson NY, Enloe CJ, Birnbaum HG, Dunlop WCN

ClinicoEconomics and Outcomes Research 2015, 7:477-488

Published Date: 15 September 2015

Original Research

Acceptance of health technology assessment submissions with incremental cost-effectiveness ratios above the cost-effectiveness threshold

Griffiths EA, Hendrich JK, Stoddart SDR, Walsh SCM

ClinicoEconomics and Outcomes Research 2015, 7:463-476

Published Date: 31 August 2015

Review

Review of the cost of venous thromboembolism

Fernandez MM, Hogue S, Preblick R, Kwong WJ

ClinicoEconomics and Outcomes Research 2015, 7:451-462

Published Date: 28 August 2015

Original Research

AbobotulinumtoxinA in the management of cervical dystonia in the United Kingdom: a budget impact analysis

Abogunrin S, Brand S, Desai K, Dinet J, Gabriel S, Harrower T

ClinicoEconomics and Outcomes Research 2015, 7:441-449

Published Date: 9 September 2015

Review

A narrative review of cost-effectiveness analysis of people living with HIV treated with HAART: from interventions to outcomes

Tse WF, Yang W, Huang W

ClinicoEconomics and Outcomes Research 2015, 7:431-439

Published Date: 11 August 2015

Original Research

Medical resource utilization for administration of trastuzumab in a New Zealand oncology outpatient setting: a time and motion study

North RT, Harvey VJ, Cox LC, Ryan SN

ClinicoEconomics and Outcomes Research 2015, 7:423-430

Published Date: 29 July 2015

Original Research

Health and economic outcomes associated with uncontrolled surgical bleeding: a retrospective analysis of the Premier Perspectives Database

Corral M, Ferko N, Hollmann S, Broder MS, Chang E

ClinicoEconomics and Outcomes Research 2015, 7:409-421

Published Date: 22 July 2015

Original Research

Retrospective analysis of drug utilization, health care resource use, and costs associated with IFN therapy for adjuvant treatment of malignant melanoma

Zhang Y, Le TK, Shaw JW, Kotapati S

ClinicoEconomics and Outcomes Research 2015, 7:397-407

Published Date: 21 July 2015

Original Research

Relationship between patient dependence and direct medical-, social-, indirect-, and informal-care costs in Spain

Darbà J, Kaskens L

ClinicoEconomics and Outcomes Research 2015, 7:387-395

Published Date: 2 July 2015

Review

Impact of noncommunicable diseases in the State of Qatar

Al-Kaabi SK, Atherton A

ClinicoEconomics and Outcomes Research 2015, 7:377-385

Published Date: 2 July 2015

Original Research

Cost and effectiveness of omega-3 fatty acid supplementation in Chinese ICU patients receiving parenteral nutrition

Wu GH, Gao J, Ji CY, Pradelli L, Xi QL, Zhuang QL

ClinicoEconomics and Outcomes Research 2015, 7:369-375

Published Date: 26 June 2015

Original Research

Association of persistent and transient worsening renal function with mortality risk, readmissions risk, length of stay, and costs in patients hospitalized with acute heart failure

Palmer JB, Friedman HS, Waltman Johnson K, Navaratnam P, Gottlieb SS

ClinicoEconomics and Outcomes Research 2015, 7:357-367

Published Date: 19 June 2015

Original Research

Economic value of in vitro fertilization in Ukraine, Belarus, and Kazakhstan

Mandrik O, Knies S, Severens JL

ClinicoEconomics and Outcomes Research 2015, 7:347-356

Published Date: 12 June 2015

Original Research

Medical costs associated with cardiovascular events among high-risk patients with hyperlipidemia

Bonafede MM, Johnson BH, Richhariya A, Gandra SR

ClinicoEconomics and Outcomes Research 2015, 7:337-345

Published Date: 9 June 2015

Original Research

Relative cost-effectiveness of an extensively hydrolyzed casein formula containing the probiotic Lactobacillus rhamnosus GG in managing infants with cow's milk allergy in Italy

Guest JF, Panca M, Ovcinnikova O, Nocerino R

ClinicoEconomics and Outcomes Research 2015, 7:325-336

Published Date: 8 June 2015

Original Research

Clinical trial simulation methods for estimating the impact of DPP-4 inhibitors on cardiovascular disease

Schuetz CA, Ong SH, Blüher M

ClinicoEconomics and Outcomes Research 2015, 7:313-323

Published Date: 5 June 2015

Original Research

Comparative effectiveness and costs of generic and brand-name gabapentin and venlafaxine in patients with neuropathic pain or generalized anxiety disorder in Spain

Sicras-Mainar A, Rejas-Gutiérrez J, Navarro-Artieda R

ClinicoEconomics and Outcomes Research 2015, 7:299-312

Published Date: 4 June 2015

Original Research

Evolution of health technology assessment: best practices of the pan-Canadian Oncology Drug Review

Rocchi A, Chabot I, Glennie J

ClinicoEconomics and Outcomes Research 2015, 7:287-298

Published Date: 3 June 2015

Original Research

Prevalence and cost of imaging in inpatient falls: the rising cost of falling

Fields J, Alturkistani T, Kumar N, Kanuri A, Salem DN, Munn S, Blazey-Martin D

ClinicoEconomics and Outcomes Research 2015, 7:281-286

Published Date: 3 June 2015

Original Research

Adherence to statin treatment following a myocardial infarction: an Italian population-based survey

Monaldi B, Bologna G, Costa GG, D'Agostino C, Ferrante F, Filice M, Grion A, Mingarelli A, Paloscia L, Tettamanti R, Veronesi C, Degli Esposti L

ClinicoEconomics and Outcomes Research 2015, 7:273-280

Published Date: 1 June 2015

Original Research

Modeling the budget impact of long-acting injectable paliperidone palmitate in the treatment of schizophrenia in Japan

Mahlich J, Nishi M, Saito Y

ClinicoEconomics and Outcomes Research 2015, 7:267-272

Published Date: 22 May 2015

Original Research

Application of a validated algorithm to estimate the effectiveness and cost of biologics for rheumatoid arthritis in the US pharmacy benefit manager context

Wu N, Bhurke S, Shah N, Harrison DJ

ClinicoEconomics and Outcomes Research 2015, 7:257-266

Published Date: 13 May 2015

Original Research

Nab-paclitaxel, docetaxel, or solvent-based paclitaxel in metastatic breast cancer: a cost-utility analysis from a Chinese health care perspective

Dranitsaris G, Yu B, King J, Kaura S, Zhang A

ClinicoEconomics and Outcomes Research 2015, 7:249-256

Published Date: 12 May 2015

Original Research

Cost-effectiveness of ranibizumab versus aflibercept in the treatment of visual impairment due to diabetic macular edema: a UK healthcare perspective

Régnier SA, Malcolm W, Haig J, Xue W

ClinicoEconomics and Outcomes Research 2015, 7:235-247

Published Date: 6 May 2015

Original Research

A potential gender bias in assessing quality of life – a standard gamble experiment among university students

Al Obaidi L, Mahlich J

ClinicoEconomics and Outcomes Research 2015, 7:227-233

Published Date: 24 April 2015

Original Research

Incorporating ulipristal acetate in the care of symptomatic uterine fibroids: a Canadian cost-utility analysis of pharmacotherapy management

Tsoi B, Blackhouse G, Ferrazzi S, Reade CJ, Chen I, Goeree R

ClinicoEconomics and Outcomes Research 2015, 7:213-225

Published Date: 17 April 2015

Original Research

Inpatient cost of treating osteoporotic fractures in mainland China: a descriptive analysis

Yang YC, Du F, Ye WY, Chen Y, Li JH, Zhang J, Nicely H, Burge R

ClinicoEconomics and Outcomes Research 2015, 7:205-212

Published Date: 13 April 2015

Original Research

Health economic evaluations of medical devices in the People's Republic of China: A systematic literature review

Zhang R, Modaresi F, Borisenko O

ClinicoEconomics and Outcomes Research 2015, 7:195-204

Published Date: 9 April 2015

Original Research

Budget impact analysis of botulinum toxin A therapy for upper limb spasticity in the United Kingdom

Abogunrin S, Hortobagyi L, Remak E, Dinet J, Gabriel S, Bakheit AM

ClinicoEconomics and Outcomes Research 2015, 7:185-193

Published Date: 1 April 2015

Original Research

The impact of chronic pain on direct medical utilization and costs in chronic obstructive pulmonary disease

Roberts MH, Mapel DW, Thomson HN

ClinicoEconomics and Outcomes Research 2015, 7:173-184

Published Date: 26 March 2015

Original Research

Disability-adjusted life years lost due to diabetes in France, Italy, Germany, Spain, and the United Kingdom: a burden of illness study

Darbà J, Kaskens L, Detournay B, Kern W, Nicolucci A, Orozco-Beltrán D, Ramírez de Arellano A

ClinicoEconomics and Outcomes Research 2015, 7:163-171

Published Date: 23 March 2015

Corrigendum

Annual biologic treatment cost for new and existing patients with moderate to severe plaque psoriasis in Greece [Corrigendum]

Fragoulakis V, Raptis E, Vitsou E, Maniadakis N

ClinicoEconomics and Outcomes Research 2015, 7:161-162

Published Date: 17 March 2015

Original Research

Costs of illness analysis in Italian patients with chronic obstructive pulmonary disease (COPD): an update

Dal Negro RW, Bonadiman L, Turco P, Tognella S, Iannazzo S

ClinicoEconomics and Outcomes Research 2015, 7:153-159

Published Date: 16 March 2015

Original Research

Cost-effectiveness of using an extensively hydrolyzed casein formula plus the probiotic Lactobacillus rhamnosus GG compared to an extensively hydrolyzed formula alone or an amino acid formula as first-line dietary management for cow’s milk allergy in the US

Ovcinnikova O, Panca M, Guest JF

ClinicoEconomics and Outcomes Research 2015, 7:145-152

Published Date: 27 February 2015

Original Research

Health services financing and delivery: analysis of policy options for Dubai, United Arab Emirates

Hamidi S

ClinicoEconomics and Outcomes Research 2015, 7:133-143

Published Date: 25 February 2015

Original Research

Medical resource utilization and costs associated with autosomal dominant polycystic kidney disease in the USA: a retrospective matched cohort analysis of private insurer data

Knight T, Schaefer C, Krasa H, Oberdhan D, Chapman A, Perrone RD

ClinicoEconomics and Outcomes Research 2015, 7:123-132

Published Date: 20 February 2015

Commentary

Health economics, equity, and efficiency: are we almost there?

Ferraz MB

ClinicoEconomics and Outcomes Research 2015, 7:119-122

Published Date: 12 February 2015

Original Research

Cost-utility of denosumab for the treatment of postmenopausal osteoporosis in Spain

Darbà J, Kaskens L, Sorio Vilela F, Lothgren M

ClinicoEconomics and Outcomes Research 2015, 7:105-117

Published Date: 9 February 2015

Original Research

Estimating the real world daily usage and cost for exenatide twice daily and liraglutide in Germany, the Netherlands, and the UK based on volumes dispensed by pharmacies

McDonell AL, Kiiskinen U, Zammit DC, Kotchie RW, Thuresson PO, Nicolay C, Haslam T, Bruinsma M, Janszen-Van Oosterhout AJ, Otto T

ClinicoEconomics and Outcomes Research 2015, 7:95-103

Published Date: 30 January 2015

Original Research

Economic evaluation of anti-TNF agents for patients with rheumatoid arthritis in Greece

Fragoulakis V, Vitsou E, Hernandez AC, Maniadakis N

ClinicoEconomics and Outcomes Research 2015, 7:85-93

Published Date: 16 January 2015

Original Research

Annual biologic treatment cost for new and existing patients with moderate to severe plaque psoriasis in Greece

Fragoulakis V, Raptis E, Vitsou E, Maniadakis N

ClinicoEconomics and Outcomes Research 2015, 7:73-83

Published Date: 8 January 2015

Original Research

End-stage renal disease in autosomal dominant polycystic kidney disease: a comparison of dialysis-related utilization and costs with other chronic kidney diseases

Brunelli SM, Blanchette CM, Claxton AJ, Roy D, Rossetti S, Gutierrez B

ClinicoEconomics and Outcomes Research 2015, 7:65-72

Published Date: 6 January 2015

Original Research

Value analysis of digital breast tomosynthesis for breast cancer screening in a commercially-insured US population

Bonafede MM, Kalra VB, Miller JD, Fajardo LL

ClinicoEconomics and Outcomes Research 2015, 7:53-63

Published Date: 12 January 2015

Original Research

Assessing the importance of predictors in unplanned hospital readmissions for chronic obstructive pulmonary disease

Yu TC, Zhou H, Suh K, Arcona S

ClinicoEconomics and Outcomes Research 2015, 7:37-51

Published Date: 6 January 2015

Original Research

Cost of HAART in Italy: multicentric evaluation and determinants from a large HIV outpatient cohort

Tontodonati M, Cenderello G, Celesia BM, Trezzi M, Ursini T, Costantini A, Marra D, Polilli E, Catalani C, Butini L, Sozio F, Mazzotta E, Sciacca A, Rizzardini G, Manzoli L, Cozzi-Lepri A, Parruti G

ClinicoEconomics and Outcomes Research 2015, 7:27-35

Published Date: 22 December 2014

Original Research

Cost–consequence analysis of long-term prophylaxis in the treatment of von Willebrand disease in the Italian context

Schinco P, Cultrera D, Valeri F, Borchiellini A, Mantuano M, Gorla F, Savarese A, Teruzzi C

ClinicoEconomics and Outcomes Research 2015, 7:17-25

Published Date: 17 December 2014

Review

Economic evaluation of first-line and maintenance treatments for advanced non-small cell lung cancer: a systematic review

Chouaïd C, Crequit P, Borget I, Vergnenegre A

ClinicoEconomics and Outcomes Research 2015, 7:9-15

Published Date: 15 December 2014

Original Research

The costs of fluid overload in the adult intensive care unit: is a small-volume infusion model a proactive solution?

Child DL, Cao Z, Seiberlich LE, Brown H, Greenberg J, Swanson A, Sewall MR, Robinson SB

ClinicoEconomics and Outcomes Research 2015, 7:1-8

Published Date: 15 December 2014

Original Research

Effect of occasional epoetin use in combination with a stable darbepoetin dosage on anemia management in hemodialysis patients

Shimamatsu K

ClinicoEconomics and Outcomes Research 2014, 6:531-535

Published Date: 9 December 2014

Review

Different strategies and cost-effectiveness in the treatment of primary open angle glaucoma

Ting NSJ, Li Yim JFT, Ng JY

ClinicoEconomics and Outcomes Research 2014, 6:523-530

Published Date: 4 December 2014

Original Research

Level, pattern, and determinants of polypharmacy and inappropriate use of medications by village doctors in a rural area of Bangladesh

Rasu RS, Iqbal M, Hanifi SMA, Moula A, Hoque S, Rasheed S, Bhuiya A

ClinicoEconomics and Outcomes Research 2014, 6:515-521

Published Date: 3 December 2014

Original Research

Seriousness, preventability, and burden impact of reported adverse drug reactions in Lombardy emergency departments: a retrospective 2-year characterization

Perrone V, Conti V, Venegoni M, Scotto S, Degli Esposti L, Sangiorgi D, Prestini L, Radice S, Clementi E, Vighi G

ClinicoEconomics and Outcomes Research 2014, 6:505-514

Published Date: 3 December 2014

Original Research

Measurement properties of painDETECT by average pain severity

Cappelleri JC, Bienen EJ, Koduru V, Sadosky A

ClinicoEconomics and Outcomes Research 2014, 6:497-504

Published Date: 6 November 2014

Original Research

Pain severity and the economic burden of neuropathic pain in the United States: BEAT Neuropathic Pain Observational Study

Schaefer C, Sadosky A, Mann R, Daniel S, Parsons B, Tuchman M, Anschel A, Stacey BR, Nalamachu S, Nieshoff E

ClinicoEconomics and Outcomes Research 2014, 6:483-496

Published Date: 29 October 2014

Original Research

Exploring the willingness to pay for a quality-adjusted life-year in the state of Penang, Malaysia

Shafie AA, Lim YW, Chua GN, Hassali MA

ClinicoEconomics and Outcomes Research 2014, 6:473-481

Published Date: 23 October 2014

Original Research

Clinical outcomes and health care costs combining metformin with sitagliptin or sulphonylureas or thiazolidinediones in uncontrolled type 2 diabetes patients

Degli Esposti L, Saragoni S, Buda S, Degli Esposti E

ClinicoEconomics and Outcomes Research 2014, 6:463-472

Published Date: 21 October 2014

Original Research

Clinical response and hospital costs associated with the empirical use of vancomycin and linezolid for hospital-acquired pneumonia in a Chinese tertiary care hospital: a retrospective cohort study

Song Y, Yang Y, Chen W, Liu W, Wang K, Li X, Wang K, Papadimitropoulos M, Montgomery W

ClinicoEconomics and Outcomes Research 2014, 6:451-461

Published Date: 17 October 2014

Original Research

Economic burden of asthma in Abu Dhabi: a retrospective study

Alzaabi A, Alseiari M, Mahboub B

ClinicoEconomics and Outcomes Research 2014, 6:445-450

Published Date: 17 October 2014

Review

A medicoeconomic review of early intervention with biologic agents in the treatment of inflammatory bowel diseases

Odes S, Greenberg D

ClinicoEconomics and Outcomes Research 2014, 6:431-443

Published Date: 8 October 2014

Original Research

Retrospective database analysis of clinical outcomes and costs for treatment of abnormal uterine bleeding among women enrolled in US Medicaid programs

Bonafede MM, Miller JD, Laughlin-Tommaso SK, Lukes AS, Meyer NM, Lenhart GM

ClinicoEconomics and Outcomes Research 2014, 6:423-429

Published Date: 8 October 2014

Original Research

Laparoscopic versus open colorectal resection for cancer and polyps: a cost-effectiveness study

Jordan J, Dowson H, Gage H, Jackson D, Rockall T

ClinicoEconomics and Outcomes Research 2014, 6:415-422

Published Date: 26 September 2014

Original Research

Budget impact analysis of antiretroviral less drug regimen simplification in HIV-positive patients on the Italian National Health Service

Restelli U, Andreoni M, Antinori A, Bonfanti M, Di Perri G, Galli M, Lazzarin A, Rizzardini G, Croce D

ClinicoEconomics and Outcomes Research 2014, 6:409-414

Published Date: 23 September 2014

Original Research

Adherence and resource use among patients treated with biologic drugs: findings from BEETLE study

Degli Esposti L, Sangiorgi D, Perrone V, Radice S, Clementi E, Perone F, Buda S

ClinicoEconomics and Outcomes Research 2014, 6:401-407

Published Date: 18 September 2014

Original Research

Impact of potential pregabalin or duloxetine drug–drug interactions on health care costs and utilization among Medicare members with fibromyalgia

Ellis JJ, Sadosky AB, Ten Eyck LL, Cappelleri JC, Brown CR, Suehs BT, Parsons B

ClinicoEconomics and Outcomes Research 2014, 6:389-399

Published Date: 14 October 2014

Original Research

Cost of tumor necrosis factor blockers per patient with rheumatoid arthritis in a multistate Medicaid population

Bonafede M, Joseph GJ, Shah N, Princic N, Harrison DJ

ClinicoEconomics and Outcomes Research 2014, 6:381-388

Published Date: 15 September 2014

Original Research

Economic burden associated with chronic constipation in Sweden: a retrospective cohort study

Bruce Wirta S, Hodgkins P, Joseph A

ClinicoEconomics and Outcomes Research 2014, 6:369-379

Published Date: 12 August 2014

Perspectives

Oncology drug health technology assessment recommendations: Canadian versus UK experiences

Chabot I, Rocchi A

ClinicoEconomics and Outcomes Research 2014, 6:357-367

Published Date: 16 July 2014

Original Research

Costs and health care resource utilization among chronic obstructive pulmonary disease patients with newly acquired pneumonia

Lin J, Li Y, Tian H, Goodman MJ, Gabriel S, Nazareth T, Turner SJ, Arcona S, Kahler KH

ClinicoEconomics and Outcomes Research 2014, 6:349-356

Published Date: 16 July 2014

Original Research

Impact of therapeutic drug monitoring of antiretroviral drugs in routine clinical management of patients infected with human immunodeficiency virus and related health care costs: a real-life study in a large cohort of patients

Perrone V, Cattaneo D, Radice S, Sangiorgi D, Federici AB, Gismondo MR, Medaglia M, Micheli V, Vimercati S, Pallone E, Degli Esposti L, Clementi E

ClinicoEconomics and Outcomes Research 2014, 6:341-348

Published Date: 14 July 2014

Review

Considerations for payers in managing hormone receptor-positive advanced breast cancer

Chitre M, Reimers KM

ClinicoEconomics and Outcomes Research 2014, 6:331-339

Published Date: 10 July 2014

Review

Cost-effectiveness of continuous erythropoietin receptor activator in anemia

Schmid H

ClinicoEconomics and Outcomes Research 2014, 6:319-330

Published Date: 3 July 2014

Original Research

Cost of opioid intravenous patient-controlled analgesia: results from a hospital database analysis and literature assessment

Palmer P, Ji X, Stephens J

ClinicoEconomics and Outcomes Research 2014, 6:311-318

Published Date: 20 June 2014

Original Research

Health policy model: long-term predictive results associated with the management of hepatitis C virus-induced diseases in Italy

Mennini FS, Marcellusi A, Andreoni M, Gasbarrini A, Salomone S, Craxì A

ClinicoEconomics and Outcomes Research 2014, 6:303-310

Published Date: 19 June 2014

Original Research

Economic impact of infections among patients with primary immunodeficiency disease receiving IVIG therapy

Menzin J, Sussman M, Munsell M, Zbrozek A

ClinicoEconomics and Outcomes Research 2014, 6:297-302

Published Date: 10 June 2014

Original Research

Comparison of the costs of nonoperative care to minimally invasive surgery for sacroiliac joint disruption and degenerative sacroiliitis in a United States commercial payer population: potential economic implications of a new minimally invasive technology

Ackerman SJ, Polly Jr DW, Knight T, Schneider K, Holt T, Cummings Jr J

ClinicoEconomics and Outcomes Research 2014, 6:283-296

Published Date: 24 May 2014

Original Research

Opioid-induced constipation in patients with chronic noncancer pain in the USA, Canada, Germany, and the UK: descriptive analysis of baseline patient-reported outcomes and retrospective chart review

Coyne KS, LoCasale RJ, Datto CJ, Sexton CC, Yeomans K, Tack J

ClinicoEconomics and Outcomes Research 2014, 6:269-281

Published Date: 23 May 2014

Original Research

Conversion of the Seattle Angina Questionnaire into EQ-5D utilities for ischemic heart disease: a systematic review and catalog of the literature

Wijeysundera HC, Farshchi-Zarabi S, Witteman W, Bennell MC

ClinicoEconomics and Outcomes Research 2014, 6:253-268

Published Date: 19 May 2014

Review

Health economics evidence for medical nutrition: are these interventions value for money in integrated care?

Walzer S, Droeschel D, Nuijten M, Chevrou-Séverac H

ClinicoEconomics and Outcomes Research 2014, 6:241-252

Published Date: 19 May 2014

Original Research

Dressing-related trauma: clinical sequelae and resource utilization in a UK setting

Charlesworth B, Pilling C, Chadwick P, Butcher M

ClinicoEconomics and Outcomes Research 2014, 6:227-239

Published Date: 28 April 2014

Review

Respiratory syncytial virus: current and emerging treatment options

Turner TL, Kopp BT, Paul G, Landgrave LC, Hayes D Jr, Thompson R

ClinicoEconomics and Outcomes Research 2014, 6:217-225

Published Date: 25 April 2014

Original Research

Drug adherence to olmesartan/amlodipine fixed combination in an Italian clinical practice setting

Degli Esposti L, Saragoni S, Buda S, Degli Esposti E

ClinicoEconomics and Outcomes Research 2014, 6:209-216

Published Date: 22 April 2014

Original Research

Group-based trajectory modeling to assess adherence to biologics among patients with psoriasis

Li Y, Zhou H, Cai B, Kahler KH, Tian H, Gabriel S, Arcona S

ClinicoEconomics and Outcomes Research 2014, 6:197-208

Published Date: 10 April 2014

Original Research

Economic evaluation of SQ-standardized grass allergy immunotherapy tablet (Grazax®) in children

Ronaldson S, Taylor M, Bech PG, Shenton R, Bufe A

ClinicoEconomics and Outcomes Research 2014, 6:187-196

Published Date: 8 April 2014

Original Research

Economic evaluation of aclidinium bromide in the management of moderate to severe COPD: an analysis over 5 years

Karabis A, Mocarski M, Eijgelshoven I, Bergman G

ClinicoEconomics and Outcomes Research 2014, 6:175-185

Published Date: 5 April 2014

Review

Economic burden of torture for a refugee host country: development of a model and presentation of a country case study

Mpinga EK, Frey C, Chastonay P

ClinicoEconomics and Outcomes Research 2014, 6:165-173

Published Date: 2 April 2014

Original Research

Economic and humanistic burden of illness in generalized anxiety disorder: an analysis of patient survey data in Europe

Toghanian S, DiBonaventura M, Järbrink K, Locklear JC

ClinicoEconomics and Outcomes Research 2014, 6:151-163

Published Date: 2 April 2014

Original Research

Economic implications of using bendamustine, alemtuzumab, or chlorambucil as a first-line therapy for chronic lymphocytic leukemia in the US: a cost-effectiveness analysis

Kongnakorn T, Sterchele JA, Salvador CG, Getsios D, Mwamburi M

ClinicoEconomics and Outcomes Research 2014, 6:141-149

Published Date: 1 April 2014

Original Research

Cost-effectiveness analysis of orbital atherectomy plus balloon angioplasty vs balloon angioplasty alone in subjects with calcified femoropopliteal lesions

Weinstock B, Dattilo R, Diage T

ClinicoEconomics and Outcomes Research 2014, 6:133-139

Published Date: 19 March 2014

Original Research

Comparative cost effectiveness of Coflex® interlaminar stabilization versus instrumented posterolateral lumbar fusion for the treatment of lumbar spinal stenosis and spondylolisthesis

Schmier JK, Halevi M, Maislin G, Ong K

ClinicoEconomics and Outcomes Research 2014, 6:125-131

Published Date: 18 March 2014

Original Research

Health economic analyses in medical nutrition: a systematic literature review

Walzer S, Droeschel D, Nuijten M, Chevrou-Séverac H

ClinicoEconomics and Outcomes Research 2014, 6:109-124

Published Date: 10 March 2014

Original Research

The cost of antiretroviral treatment service for patients with HIV/AIDS in a central outpatient clinic in Vietnam

Nguyen LT, Tran BX, Tran CT, Le HT, Tran SV

ClinicoEconomics and Outcomes Research 2014, 6:101-108

Published Date: 21 February 2014

Original Research

Predictors of biologic treatment of psoriasis: a non-interventional study

Puig L, Fan T, Ding Q, Smith NE

ClinicoEconomics and Outcomes Research 2014, 6:93-100

Published Date: 17 February 2014

Original Research

Antibiotic expected effectiveness and cost under real life microbiology: evaluation of ertapenem and ceftriaxone in the treatment of community-acquired pneumonia for elderly patients in Spain

Grau S, Lozano V, Valladares A, Cavanillas R, Xie Y, Nocea G

ClinicoEconomics and Outcomes Research 2014, 6:83-92

Published Date: 13 February 2014

Original Research

Duloxetine treatment adherence across mental health and chronic pain conditions

Able SL, Cui Z, Shen W

ClinicoEconomics and Outcomes Research 2014, 6:75-81

Published Date: 11 February 2014

Original Research

Management of sacroiliac joint disruption and degenerative sacroiliitis with nonoperative care is medical resource-intensive and costly in a United States commercial payer population

Ackerman SJ, Polly Jr DW, Knight T, Holt T, Cummings J

ClinicoEconomics and Outcomes Research 2014, 6:63-74

Published Date: 11 February 2014

Original Research

Cost-effectiveness of ticagrelor versus clopidogrel in patients with acute coronary syndromes in Canada

Grima DT, Brown ST, Kamboj L, Bainey KR, Goeree R, Oh P, Ramanathan K, Goodman SG

ClinicoEconomics and Outcomes Research 2014, 6:49-62

Published Date: 24 January 2014

Original Research

Cost-effectiveness analysis of Mammostrat® compared with Oncotype DX® to inform the treatment of breast cancer

Mislick K, Schonfeld W, Bodnar C, Tong KB

ClinicoEconomics and Outcomes Research 2014, 6:37-47

Published Date: 16 January 2014

Original Research

Out-of-pocket cost of managing sick newborns in Enugu, southeast Nigeria

Ekwochi U, Osuorah DC, Ndu IK, Ezenwosu OU, Amadi OF, Nwokoye IC, Odetunde OI

ClinicoEconomics and Outcomes Research 2014, 6:29-35

Published Date: 16 January 2014

Original Research

Estimation of utility values from visual analog scale measures of health in patients undergoing cardiac surgery

Oddershede L, Andreasen JJ, Ehlers L

ClinicoEconomics and Outcomes Research 2014, 6:21-27

Published Date: 10 January 2014

Original Research

Health care-resource utilization before and after natalizumab initiation in multiple sclerosis patients in the US

Bonafede MM, Johnson BH, Watson C

ClinicoEconomics and Outcomes Research 2014, 6:11-20

Published Date: 19 December 2013

Original Research

Budget impact analysis of the fentanyl buccal tablet for treatment of breakthrough cancer pain

Darbà J, Kaskens L, Sánchez-de la Rosa R

ClinicoEconomics and Outcomes Research 2014, 6:1-9

Published Date: 16 December 2013

Original Research

C-QUALITY: cost and quality-of-life pharmacoeconomic analysis of antidepressants used in major depressive disorder in the regional Italian settings of Veneto and Sardinia

Mencacci C, Aguglia E, Biggio G, Cappellari L, Di Sciascio G, Fagiolini A, Maina G, Tortorella A, Katz P, Ripellino C

ClinicoEconomics and Outcomes Research 2013, 5:611-621

Published Date: 3 December 2013

Review

Health economic evidence of 5% lidocaine medicated plaster in post-herpetic neuralgia

Liedgens H, Obradovic M, Nuijten M

ClinicoEconomics and Outcomes Research 2013, 5:597-609

Published Date: 25 November 2013

Original Research

Persistence with weekly and monthly bisphosphonates among postmenopausal women: analysis of a US pharmacy claims administrative database

Fan T, Zhang Q, Sen SS

ClinicoEconomics and Outcomes Research 2013, 5:589-595

Published Date: 19 November 2013

Original Research

Comparison of the costs of nonoperative care to minimally invasive surgery for sacroiliac joint disruption and degenerative sacroiliitis in a United States Medicare population: potential economic implications of a new minimally-invasive technology

Ackerman SJ, Polly Jr DW, Knight T, Schneider K, Holt T, Cummings J

ClinicoEconomics and Outcomes Research 2013, 5:575-587

Published Date: 20 November 2013

Review

Challenges in measuring and valuing productivity costs, and their relevance in mood disorders

Lensberg BR, Drummond MF, Danchenko N, Despiégel N, François C

ClinicoEconomics and Outcomes Research 2013, 5:565-573

Published Date: 18 November 2013

Original Research

Cost-effectiveness of modified-release prednisone in the treatment of moderate to severe rheumatoid arthritis with morning stiffness based on directly elicited public preference values

Dunlop W, Iqbal I, Khan I, Ouwens M, Heron L

ClinicoEconomics and Outcomes Research 2013, 5:555-564

Published Date: 30 October 2013

Original Research

Budget impact analysis of conversion from cyclosporine to sirolimus as immunosuppressive medication in renal transplantation therapy

Foroutan N, Rasekh HR, Salamzadeh J, Jamshidi HR, Nafar M

ClinicoEconomics and Outcomes Research 2013, 5:545-553

Published Date: 18 October 2013

Review

A systematic review of the effectiveness of taxes on nonalcoholic beverages and high-in-fat foods as a means to prevent obesity trends

Maniadakis N, Kapaki V, Damianidi L, Kourlaba G

ClinicoEconomics and Outcomes Research 2013, 5:519-543

Published Date: 22 October 2013

Original Research

Outcomes associated with conventional versus lipid-based formulations of amphotericin B in propensity-matched groups

Campbell RS, Chaudhari P, Hays HD, Taylor RJ, Nathanson BH, Bozzette SA, Horn DL

ClinicoEconomics and Outcomes Research 2013, 5:507-517

Published Date: 24 October 2013

Original Research

Real-world outcomes of initiating insulin glargine-based treatment versus premixed analog insulins among US patients with type 2 diabetes failing oral antidiabetic drugs

Baser O, Tangirala K, Wei W, Xie L

ClinicoEconomics and Outcomes Research 2013, 5:497-505

Published Date: 3 October 2013

Review

Economic evaluation of initial antiretroviral therapy for HIV-infected patients: an update of Italian guidelines

Colombo GL, Matteo SD, Antinori A, Medaglia M, Murachelli S, Rizzardini G

ClinicoEconomics and Outcomes Research 2013, 5:489-496

Published Date: 3 October 2013

Review

Cost of noninfectious comorbidities in patients with HIV

Guaraldi G, Zona S, Menozzi M, Carli F, Bagni P, Berti A, Rossi E, Orlando G, Zoboli G, Palella F

ClinicoEconomics and Outcomes Research 2013, 5:481-488

Published Date: 23 September 2013

Original Research

Using observational data to inform the design of a prospective effectiveness study for a novel insulin delivery device

Grabner M, Chen Y, Nguyen M, Abbott SD, Quimbo R

ClinicoEconomics and Outcomes Research 2013, 5:471-479

Published Date: 23 September 2013

Original Research

Long-term cost-effectiveness of atypical antipsychotics in the treatment of adults with schizophrenia in the US

O'Day K, Rajagopalan K, Meyer K, Pikalov A, Loebel A

ClinicoEconomics and Outcomes Research 2013, 5:459-470

Published Date: 13 September 2013

Original Research

Economic burden of inpatient and outpatient antibiotic treatment for methicillin-resistant Staphylococcus aureus complicated skin and soft-tissue infections: a comparison of linezolid, vancomycin, and daptomycin

Stephens JM, Gao X, Patel DA, Verheggen BG, Shelbaya A, Haider S

ClinicoEconomics and Outcomes Research 2013, 5:447-457

Published Date: 16 September 2013

Original Research

Cost-effectiveness of the once-daily efavirenz/emtricitabine/tenofovir tablet compared with the once-daily elvitegravir/cobicistat/emtricitabine/tenofovir tablet as first-line antiretroviral therapy in HIV-infected adults in the US

Juday T, Correll T, Anene A, Broder MS, Ortendahl J, Bentley T

ClinicoEconomics and Outcomes Research 2013, 5:437-445

Published Date: 2 September 2013

Original Research

Early enteral nutrition in critical illness: a full economic analysis using US costs

Doig GS, Chevrou-Séverac H, Simpson F

ClinicoEconomics and Outcomes Research 2013, 5:429-436

Published Date: 23 August 2013

Original Research

Cost and clinical consequences of smoking cessation in outpatients after cardiovascular disease: a retrospective cohort study

Sicras-Mainar A, Díaz-Cerezo S, Sanz de Burgoa V, Navarro-Artieda R

ClinicoEconomics and Outcomes Research 2013, 5:419-427

Published Date: 19 August 2013

Review

The personal, societal, and economic burden of schizophrenia in the People's Republic of China: implications for antipsychotic therapy

Montgomery W, Liu L, Stensland MD, Xue HB, Treuer T, Ascher-Svanum H

ClinicoEconomics and Outcomes Research 2013, 5:407-418

Published Date: 14 August 2013

Original Research

Impact of scribes on patient interaction, productivity, and revenue in a cardiology clinic: a prospective study

Bank AJ, Obetz C, Konrardy A, Khan A, Pillai KM, McKinley BJ, Gage RM, Turnbull MA, Kenney WO

ClinicoEconomics and Outcomes Research 2013, 5:399-406

Published Date: 9 August 2013

Original Research

Economic evaluation of highly purified human menopausal gonadotropin versus recombinant human follicle-stimulating hormone in fresh and frozen in vitro fertilization/intracytoplasmic sperm-injection cycles in Sweden

Wex J, Abou-Setta AM

ClinicoEconomics and Outcomes Research 2013, 5:381-397

Published Date: 9 August 2013

Original Research

Early parenteral nutrition in critically ill patients with short-term relative contraindications to early enteral nutrition: a full economic analysis of a multicenter randomized controlled trial based on US costs

Doig GS, Simpson F

ClinicoEconomics and Outcomes Research 2013, 5:369-379

Published Date: 22 July 2013

Original Research

Resource use and costs of exenatide bid or insulin in clinical practice: the European CHOICE study

Kiiskinen U, Matthaei S, Reaney M, Mathieu C, Östenson C-G, Krarup T, Theodorakis M, Kiljański J, Salaun-Martin C, Sapin H, Guerci B

ClinicoEconomics and Outcomes Research 2013, 5:355-367

Published Date: 11 July 2013

Original Research

Retrospective claims analysis of best supportive care costs and survival in a US metastatic renal cell population

Henk HJ, Chen C, Benedict A, Sullivan J, Teitelbaum A

ClinicoEconomics and Outcomes Research 2013, 5:347-354

Published Date: 9 July 2013

Original Research

Changes in quality of care and costs induced by implementation of a diabetes program in a social security entity of Argentina

González L, Elgart JF, Calvo H, Gagliardino JJ

ClinicoEconomics and Outcomes Research 2013, 5:337-345

Published Date: 4 July 2013

Original Research

Cost-effectiveness of bazedoxifene versus raloxifene in the treatment of postmenopausal women in Spain

Darbà J, Pérez-Álvarez N, Kaskens L, Holgado-Pérez S, Racketa J, Rejas J

ClinicoEconomics and Outcomes Research 2013, 5:327-336

Published Date: 5 July 2013

Original Research

Cost-effectiveness of zofenopril in patients with left ventricular systolic dysfunction after acute myocardial infarction: a post hoc analysis of SMILE-4

Borghi C, Ambrosioni E, Omboni S, Cicero AFG, Bacchelli S, Degli Esposti D, Novo S, Vinereanu D, Ambrosio G, Reggiardo G, Zava D

ClinicoEconomics and Outcomes Research 2013, 5:317-325

Published Date: 8 July 2013

Original Research

A cost-of-illness study of spina bifida in Italy

Colombo GL, Di Matteo S, Vinci M, Gatti C, Pascali MP, De Gennaro M, Macrellino E, Mosiello G, Redaelli T, Schioppa F, Dieci C

ClinicoEconomics and Outcomes Research 2013, 5:309-316

Published Date: 2 July 2013

Original Research

Cost–utility analysis for platinum-sensitive recurrent ovarian cancer therapy in South Korea: results of the polyethylene glycolated liposomal doxorubicin/carboplatin sequencing model

Lee HY, Yang BM, Hong JM, Lee TJ, Kim BG, Kim JW, Kim YT, Kim YM, Kang S

ClinicoEconomics and Outcomes Research 2013, 5:297-307

Published Date: 3 July 2013

Original Research

Fluid overload is associated with increases in length of stay and hospital costs: pooled analysis of data from more than 600 US hospitals

Magee G, Zbrozek A

ClinicoEconomics and Outcomes Research 2013, 5:289-296

Published Date: 26 June 2013

Review

The costs of traumatic brain injury: a literature review

Humphreys I, Wood RL, Phillips CJ, Macey S

ClinicoEconomics and Outcomes Research 2013, 5:281-287

Published Date: 26 June 2013

Original Research

Demographics and clinical and economic characteristics of patients receiving total hip arthroplasty with and without muscle atrophy/weakness

Wu N, Chen SY, Lee YC, Zhao Y

ClinicoEconomics and Outcomes Research 2013, 5:271-280

Published Date: 25 June 2013

Original Research

Leuprolide acetate 1-, 3- and 6-monthly depot formulations in androgen deprivation therapy for prostate cancer in nine European countries: evidence review and economic evaluation

Wex J, Sidhu M, Odeyemi I, Abou-Setta AM, Retsa P, Tombal B

ClinicoEconomics and Outcomes Research 2013, 5:257-269

Published Date: 24 June 2013

Original Research

Estimating the long-term effects of in vitro fertilization in Greece: an analysis based on a lifetime-investment model

Fragoulakis V, Maniadakis N

ClinicoEconomics and Outcomes Research 2013, 5:247-255

Published Date: 20 June 2013

Review

The clinical and economic burden of chronic obstructive pulmonary disease in the USA

Guarascio AJ, Ray SM, Finch CK, Self TH

ClinicoEconomics and Outcomes Research 2013, 5:235-245

Published Date: 17 June 2013

Original Research

Medical technology as a key driver of rising health expenditure: disentangling the relationship

Sorenson C, Drummond M, Bhuiyan Khan B

ClinicoEconomics and Outcomes Research 2013, 5:223-234

Published Date: 30 May 2013

Original Research

Antiretroviral treatment switch strategies for lowering the costs of antiretroviral therapy in subjects with suppressed HIV-1 viremia in Spain

Llibre JM, Cardona G, Santos JR, Andreu A , Estrada JO, Ara J, Bonafont X, Clotet B

ClinicoEconomics and Outcomes Research 2013, 5:215-221

Published Date: 23 May 2013

Original Research

Annual cost of hospitalization, inpatient rehabilitation, and sick leave for head and neck cancers in Germany

Klussmann JP, Schädlich PK, Chen X, Rémy V

ClinicoEconomics and Outcomes Research 2013, 5:203-213

Published Date: 16 May 2013

Original Research

Glycemic control and diabetes-related health care costs in type 2 diabetes; retrospective analysis based on clinical and administrative databases

Degli Esposti L, Saragoni S, Buda S, Sturani A, Degli Esposti E

ClinicoEconomics and Outcomes Research 2013, 5:193-201

Published Date: 14 May 2013

Original Research

Homozygous familial hypercholesterolemia (HoFH) in Germany: an epidemiological survey

Walzer S, Travers K, Rieder S, Erazo-Fischer E, Matusiewicz D

ClinicoEconomics and Outcomes Research 2013, 5:189-192

Published Date: 3 May 2013

Original Research

Clinical and economic outcomes among hospitalized patients with acute coronary syndrome: an analysis of a national representative Medicare population

Chen SY, Crivera C, Stokes M, Boulanger L, Schein J

ClinicoEconomics and Outcomes Research 2013, 5:181-188

Published Date: 1 May 2013

Original Research

Health-resource use and costs associated with fibromyalgia in France, Germany, and the United States

Knight T, Schaefer C, Chandran A, Zlateva G, Winkelmann A, Perrot S

ClinicoEconomics and Outcomes Research 2013, 5:171-180

Published Date: 23 April 2013

Original Research

Comparison of health care resource utilization and costs among patients with GERD on once-daily or twice-daily proton pump inhibitor therapy

Mody R, Eisenberg D, Hou L, Kamat S, Singer J, Gerson LB

ClinicoEconomics and Outcomes Research 2013, 5:161-169

Published Date: 22 April 2013

Original Research

Improving the economic and humanistic outcomes for diabetic patients: making a case for employer-sponsored medication therapy management

Pinto SL, Kumar J, Partha G, Bechtol RA

ClinicoEconomics and Outcomes Research 2013, 5:153-159

Published Date: 11 April 2013

Review

Update on the management of cirrhosis – focus on cost-effective preventative strategies

Neff GW, Kemmer N, Duncan C, Alsina A

ClinicoEconomics and Outcomes Research 2013, 5:143-152

Published Date: 12 April 2013

Review

Update on the treatment of non-small-cell lung cancer: focus on the cost-effectiveness of new agents

Vergnenègre A, Borget I, Chouaid C

ClinicoEconomics and Outcomes Research 2013, 5:137-141

Published Date: 10 April 2013

Review

An Italian cost-effectiveness analysis of paclitaxel albumin (nab-paclitaxel) versus conventional paclitaxel for metastatic breast cancer patients: the COSTANza study

Lazzaro C, Bordonaro R, Cognetti F, Fabi A, De Placido S, Arpino G, Marchetti P, Botticelli A, Pronzato P, Martelli E

ClinicoEconomics and Outcomes Research 2013, 5:125-135

Published Date: 11 April 2013

Short Report

Follow-up analysis of federal process of care data reported from three acute care hospitals in rural Appalachia

Sills ES, Chiriac L, Vaughan D, Jones CA, Salem SA

ClinicoEconomics and Outcomes Research 2013, 5:119-124

Published Date: 27 March 2013

Review

The role and uptake of private health insurance in different health care systems: are there lessons for developing countries?

Odeyemi IA, Nixon J

ClinicoEconomics and Outcomes Research 2013, 5:109-118

Published Date: 5 March 2013

Original Research

Health care costs associated with venous thromboembolism in selected high-risk ambulatory patients with solid tumors undergoing chemotherapy in the United States

Khorana AA, Dalal MR, Lin J, Connolly GC

ClinicoEconomics and Outcomes Research 2013, 5:101-108

Published Date: 13 February 2013

Review

Cost-effectiveness evaluation of escitalopram in major depressive disorder in Italy

Mencacci C, Di Sciascio G, Katz P, Ripellino C

ClinicoEconomics and Outcomes Research 2013, 5:87-99

Published Date: 7 February 2013

Original Research

Do different clinical evidence bases lead to discordant health-technology assessment decisions? An in-depth case series across three jurisdictions

Spinner DS, Birt J, Walter JW, Bowman L, Mauskopf J, Drummond MF, Copley-Merriman C

ClinicoEconomics and Outcomes Research 2013, 5:69-85

Published Date: 30 January 2013

Original Research

Antiretroviral therapy in HIV-infected patients: a proposal to assess the economic value of the single-tablet regimen

Colombo GL, Di Matteo S, Maggiolo F

ClinicoEconomics and Outcomes Research 2013, 5:59-68

Published Date: 12 February 2013

Original Research

Medical costs and utilization in patients with depression treated with adjunctive atypical antipsychotic therapy

Nadkarni A, Kalsekar I, You M, Forbes R, Hebden T

ClinicoEconomics and Outcomes Research 2013, 5:49-57

Published Date: 20 January 2013

Original Research

Health care costs before and after diagnosis of depression in patients with unexplained pain: a retrospective cohort study using the United Kingdom General Practice Research Database

Reed C, Hong J, Novick D, Lenox-Smith A, Happich M

ClinicoEconomics and Outcomes Research 2013, 5:37-47

Published Date: 14 January 2013

Original Research

Estimating the willingness to pay for a quality-adjusted life year in Thailand: does the context of health gain matter?

Thavorncharoensap M, Teerawattananon Y, Natanant S, Kulpeng W, Yothasamut J, Werayingyong P

ClinicoEconomics and Outcomes Research 2013, 5:29-36

Published Date: 10 January 2013

Original Research

Cost-effectiveness of dronedarone and standard of care compared with standard of care alone: US results of an ATHENA lifetime model

Reynolds MR, Nilsson J, Åkerborg Ö, Jhaveri M, Lindgren P

ClinicoEconomics and Outcomes Research 2013, 5:19-28

Published Date: 8 January 2013

Review

Epidemiology of falls and osteoporotic fractures: a systematic review

Morrison A, Fan T, Sen SS, Weisenfluh L

ClinicoEconomics and Outcomes Research 2013, 5:9-18

Published Date: 28 December 2012

Review

Analysis of disease patterns and cost of treatments for prevention of deep venous thrombosis after total knee or hip replacement: results from the Practice Analysis of THromboprophylaxis after Orthopaedic Surgery (PATHOS) study

Degli Esposti L, Didoni G, Simon T, Buda S, Sangiorgi D, Degli Esposti E

ClinicoEconomics and Outcomes Research 2013, 5:1-7

Published Date: 28 December 2012

Original Research

Increase in direct diabetes-related costs and resource use in the 6 months following initiation of insulin in patients with type 2 diabetes in five European countries: data from the INSTIGATE study

Jones S, Castell C, Goday A, Smith HT, Nicolay C, Simpson A, Salaun-Martin C

ClinicoEconomics and Outcomes Research 2012, 4:383-393

Published Date: 20 December 2012

Original Research

Cost and appropriateness of treating asthma with fixed-combination drugs in local health care units in Italy

Ruggeri I, Bragato D, Colombo GL, Valla E, Di Matteo S

ClinicoEconomics and Outcomes Research 2012, 4:375-382

Published Date: 5 December 2012

Perspectives

The use of comparative effectiveness research to inform policy decisions on the inclusion of bevacizumab for the treatment of macular diseases in Thailand's pharmaceutical benefit package

Anothaisintawee T, Leelahavarong P, Ratanapakorn T, Teerawattananon Y

ClinicoEconomics and Outcomes Research 2012, 4:361-374

Published Date: 6 December 2012

Original Research

Budget impact analysis of boceprevir and telaprevir for the treatment of hepatitis C genotype 1 infection

Thorlund K, Druyts E, El Khoury AC, Mills EJ

ClinicoEconomics and Outcomes Research 2012, 4:349-359

Published Date: 16 November 2012

Original Research

The impact of initial statin treatment decisions on cardiovascular outcomes in clinical care settings: estimates using the Archimedes Model

van Herick A, Schuetz CA, Alperin P, Bullano MF, Balu S, Gandhi S

ClinicoEconomics and Outcomes Research 2012, 4:337-347

Published Date: 9 November 2012

Original Research

Economic analysis of Heart and Stroke Foundation of Ontario's Hypertension Management Initiative

de Oliveira C, Wijeysundera HC, Tobe SW, Moy Lum-Kwong M, Von Sychowski S, Wang X, Tu JV, Krahn MD

ClinicoEconomics and Outcomes Research 2012, 4:323-336

Published Date: 13 November 2012

Original Research

Cost-effectiveness of candesartan versus losartan in the primary preventive treatment of hypertension

Granström O, Levin LA, Henriksson M

ClinicoEconomics and Outcomes Research 2012, 4:313-322

Published Date: 1 November 2012

Original Research

Impact of dry eye on work productivity

Yamada M, Mizuno Y, Shigeyasu C

ClinicoEconomics and Outcomes Research 2012, 4:307-312

Published Date: 10 October 2012

Original Research

Societal savings in patients with advanced non-squamous non-small-cell lung cancer receiving bevacizumab-based versus non-bevacizumab-based treatments in France, Germany, Italy, and Spain

Lister J, Stanisic S, Kaier K, Hagist C, Gultyaev D, Walzer S

ClinicoEconomics and Outcomes Research 2012, 4:299-305

Published Date: 4 October 2012

Original Research

Cost-effectiveness analysis of intranasal live attenuated vaccine (LAIV) versus injectable inactivated influenza vaccine (TIV) for Canadian children and adolescents

Tarride JE, Burke N, Von Keyserlingk C, O'Reilly D, Xie F, Goeree R

ClinicoEconomics and Outcomes Research 2012, 4:287-298

Published Date: 4 October 2012

Original Research

Two-factor theory – at the intersection of health care management and patient satisfaction

Bohm J

ClinicoEconomics and Outcomes Research 2012, 4:277-285

Published Date: 4 October 2012

Original Research

Maintenance erlotinib in advanced nonsmall cell lung cancer: cost-effectiveness in EGFR wild-type across Europe

Walleser S, Ray J, Bischoff H, Vergnenègre A, Rosery H, Chouaid C, Heigener D, de Castro Carpeño J, Tiseo M, Walzer S

ClinicoEconomics and Outcomes Research 2012, 4:269-275

Published Date: 14 September 2012

Review

Calcipotriol and betamethasone dipropionate in the treatment of mild-to-moderate psoriasis: a cost-effectiveness analysis of the ointment versus gel formulation

Colombo GL, Di Matteo S, Bruno G, Girolomoni G, Vena GA

ClinicoEconomics and Outcomes Research 2012, 4:261-268

Published Date: 13 September 2012

Original Research

Budget impact analysis of two immunotherapy products for treatment of grass pollen-induced allergic rhinoconjunctivitis

Rønborg SM, Svendsen UG, Micheelsen JS, Ytte L, Andreasen JN, Ehlers L

ClinicoEconomics and Outcomes Research 2012, 4:253-260

Published Date: 11 September 2012

Review

Cost of human immunodeficiency virus infection in Italy, 2007–2009: effective and expensive, are the new drugs worthwhile?

Rizzardini G, Restelli U, Bonfanti P, Porazzi E, Ricci E, Foglia E, Carenzi L, Croce D

ClinicoEconomics and Outcomes Research 2012, 4:245-252

Published Date: 5 September 2012

Original Research

Cost comparison of second-line treatment options for late stage non-small-cell lung cancer: cost analysis for Italy

Schwander B, Ravera S, Giuliani G, Nuijten M, Walzer S

ClinicoEconomics and Outcomes Research 2012, 4:237-243

Published Date: 3 September 2012

Original Research

Cost-effectiveness of entecavir versus adefovir for the treatment of chronic hepatitis B in patients with decompensated cirrhosis from a third-party US payer perspective

Tsai N, Jeffers L, Cragin L, Sorensen S, Su W, Rosenblatt L, Tang H, Hebden T, Juday T

ClinicoEconomics and Outcomes Research 2012, 4:227-235

Published Date: 23 August 2012

Review

Cost of rheumatoid arthritis in a selected population from Argentina in the prebiologic therapy era

Catay E, Castel del Cid C, Narváez L, Velozo EJ, Rosa JE, Catoggio LJ, Soriano ER

ClinicoEconomics and Outcomes Research 2012, 4:219-225

Published Date: 23 August 2012

Original Research

Burden of Crohn’s disease: economics and quality of life aspects in Italy

Benedini V, Caporaso N, Corazza GR, Rossi Z, Fornaciari G, Cottone M, Frosini G, Caruggi M, Ottolini C, Colombo GL

ClinicoEconomics and Outcomes Research 2012, 4:209-218

Published Date: 24 July 2012

Review

Economic evaluation of bevacizumab in the treatment of non-small cell lung cancer (NSCLC)

Chien C-R, Shih Y-C,

ClinicoEconomics and Outcomes Research 2012, 4:201-208

Published Date: 25 July 2012

Review

New strategies for lowering the costs of antiretroviral treatment and care for people with HIV/AIDS in the United Kingdom

Gazzard B, Moecklinghoff C, Hill A

ClinicoEconomics and Outcomes Research 2012, 4:193-200

Published Date: 12 July 2012

Original Research

Economic evaluation of alternative assisted reproduction techniques in management of infertility in Greece

Fragoulakis V, Kourlaba G, Tarlatzis B, Mastrominas M, Maniadakis N

ClinicoEconomics and Outcomes Research 2012, 4:185-192

Published Date: 12 July 2012

Review

State of health economic evaluation research in Saudi Arabia: a review

Al-Aqeel SA

ClinicoEconomics and Outcomes Research 2012, 4:177-184

Published Date: 5 July 2012

Original Research

Retrospective US database analysis of drug utilization patterns, health care resource use, and costs associated with adjuvant interferon alfa-2b therapy for treatment of malignant melanoma following surgery

Hackshaw MD, Krishna A, Mauro DJ

ClinicoEconomics and Outcomes Research 2012, 4:169-176

Published Date: 18 June 2012

Original Research

Pregabalin versus SSRIs and SNRIs in benzodiazepine-refractory outpatients with generalized anxiety disorder: a post hoc cost-effectiveness analysis in usual medical practice in Spain

De Salas-Cansado M, Olivares JM, Álvarez E, Carrasco JL, Barrueta A, Rejas J

ClinicoEconomics and Outcomes Research 2012, 4:157-168

Published Date: 13 June 2012

Review

Techniques for estimating health care costs with censored data: an overview for the health services researcher

Wijeysundera HC, Wang X, Tomlinson G, Ko DT, Krahn MD

ClinicoEconomics and Outcomes Research 2012, 4:145-155

Published Date: 1 June 2012

Original Research

Economic evaluation of statins in high-risk patients treated for primary and secondary prevention of cardiovascular disease in Greece

Fragoulakis V, Kourlaba G, Maniadakis N

ClinicoEconomics and Outcomes Research 2012, 4:135-143

Published Date: 29 May 2012

Original Research

Economic evaluation of intravenous iron treatments in the management of anemia patients in Greece

Fragoulakis V, Kourlaba G, Goumenos D, Konstantoulakis M, Maniadakis N

ClinicoEconomics and Outcomes Research 2012, 4:127-134

Published Date: 4 May 2012

Original Research

Forecast model for the evaluation of economic resources employed in the health care of patients with HIV infection

Sacchi P, Patruno SFA, Bruno R, Cima SMB, Previtali P, Franchini A, Nicolini L, Rognoni C, Sacchi L, Bellazzi R, Filice G

ClinicoEconomics and Outcomes Research 2012, 4:117-126

Published Date: 11 May 2012

Review

Evaluating the cost utility of racecadotril for the treatment of acute watery diarrhea in children: the RAWD model

Rautenberg TA, Zerwes U, Foerster D, Aultman R

ClinicoEconomics and Outcomes Research 2012, 4:109-116

Published Date: 20 April 2012

Review

The economic impact of enoxaparin versus unfractionated heparin for prevention of venous thromboembolism in acute ischemic stroke patients

Pineo GF, Lin J, Annemans L

ClinicoEconomics and Outcomes Research 2012, 4:99-107

Published Date: 23 April 2012

Original Research

Impact of screening and early detection of impaired fasting glucose tolerance and type 2 diabetes in Canada: a Markov model simulation

Mortaz S, Wessman C, Duncan R, Gray R, Badawi A

ClinicoEconomics and Outcomes Research 2012, 4:91-97

Published Date: 10 April 2012

Review

Costs and clinical consequences of suboptimal atrial fibrillation management

Singh SN

ClinicoEconomics and Outcomes Research 2012, 4:79-90

Published Date: 26 March 2012

Review

Cost considerations in the management of atrial fibrillation – impact of dronedarone

Khaykin Y, Shamiss Y

ClinicoEconomics and Outcomes Research 2012, 4:67-78

Published Date: 6 March 2012

Original Research

Cost-effectiveness study of oral hypoglycemic agents in the treatment of outpatients with type 2 diabetes attending a public primary care clinic in Mexico City

Díaz de León-Castañeda C, Altagracia-Martínez M, Kravzov-Jinich J, Cárdenas-Elizalde MR, Moreno-Bonett C, Martínez-Núñez JM

ClinicoEconomics and Outcomes Research 2012, 4:57-65

Published Date: 7 March 2012

Original Research

Health expenditure comparison of extended-release metoprolol succinate and immediate-release metoprolol tartarate

Vaidya V, Patel P

ClinicoEconomics and Outcomes Research 2012, 4:49-56

Published Date: 7 February 2012

Original Research

Treatment profiles and costs of patients with chronic pain in the population setting

Sicras Mainar A, Navarro Artieda R, Villoria Morillo J, Esquivias Escobar A

ClinicoEconomics and Outcomes Research 2012, 4:39-47

Published Date: 26 January 2012

Original Research

Cross-market cost-effectiveness analysis of erlotinib as first-line maintenance treatment for patients with stable non-small cell lung cancer

Vergnenègre A, Ray JA, Chouaid C, Grossi F, Bischoff HG, Heigener DF, Walzer S

ClinicoEconomics and Outcomes Research 2012, 4:31-37

Published Date: 26 January 2012

Original Research

Health status, hospitalizations, day procedures, and physician costs associated with body mass index (BMI) levels in Ontario, Canada

Tarride JE, Haq M, Taylor VH, Sharma AM, Nakhai-Pour HR, O'Reilly D, Xie F, Dolovich L, Goeree R

ClinicoEconomics and Outcomes Research 2012, 4:21-30

Published Date: 24 January 2012

Original Research

Predictors of antipsychotic monotherapy with olanzapine during a 1-year naturalistic study of schizophrenia patients in Japan

Ye W, Ascher-Svanum H, Flynn JA, Tanji Y, Takahashi M

ClinicoEconomics and Outcomes Research 2012, 4:13-19

Published Date: 13 January 2012

Original Research

Cost-effectiveness of rosuvastatin in comparison with generic atorvastatin and simvastatin in a Swedish population at high risk of cardiovascular events

Gandhi SK, Jensen MM, Fox KM, Smolen L, Olsson AG, Paulsson T

ClinicoEconomics and Outcomes Research 2012, 4:1-11

Published Date: 10 January 2012

Methodology

Cost-utility analysis of immune tolerance induction therapy versus on-demand treatment with recombinant factor VII for hemophilia A with high titer inhibitors in Iran

Rasekh HR, Imani A, Karimi M, Golestani M

ClinicoEconomics and Outcomes Research 2011, 3:207-212

Published Date: 23 November 2011

Review

Cost-effectiveness analysis of initial HIV treatment under Italian guidelines

Colombo GL, Colangeli V, Di Biagio A, Di Matteo S, Viscoli C, Viale P

ClinicoEconomics and Outcomes Research 2011, 3:197-205

Published Date: 31 October 2011

Original Research

Impact of early intervention and disease modification in patients with predementia Alzheimer’s disease: a Markov model simulation

Budd D, Burns LC, Guo Z, L’Italien G, Lapuerta P

ClinicoEconomics and Outcomes Research 2011, 3:189-195

Published Date: 7 October 2011

Corrigendum

Zoellner Y, Balp MM, Gili Marco A

ClinicoEconomics and Outcomes Research 2011, 3:187-188

Published Date: 6 September 2011

Original Research

Role of centralized review processes for making reimbursement decisions on new health technologies in Europe

Stafinski T, Menon D, Davis C, McCabe C

ClinicoEconomics and Outcomes Research 2011, 3:117-186

Published Date: 30 August 2011

Original Research

The role of galenic innovation in improving treatment compliance and persistence: three case studies

Zoellner Y, Balp MM, Gili Marco A

ClinicoEconomics and Outcomes Research 2011, 3:109-116

Published Date: 4 August 2011

Original Research

Retrospective drug utilization review: impact of pharmacist interventions on physician prescribing

Angalakuditi M, Gomes J

ClinicoEconomics and Outcomes Research 2011, 3:105-108

Published Date: 27 June 2011

Review

Transferability of health technology assessments and economic evaluations: a systematic review of approaches for assessment and application

Goeree R, He J, O'Reilly D, Tarride J-E, Xie F, Lim M, Burke N

ClinicoEconomics and Outcomes Research 2011, 3:89-104

Published Date: 2 June 2011

Original Research

Cost-effectiveness of early responders versus early nonresponders to atypical antipsychotic therapy

Peng X, Ascher-Svanum H, Faries DE, Stauffer VL, Kollack-Walker S, Kinon BJ, Kane JM

ClinicoEconomics and Outcomes Research 2011, 3:79-87

Published Date: 20 April 2011

Original Research

The economic burden of TNFα inhibitors and other biologic treatments in Norway

Jan Norum, Wenche Koldingsnes, Torfinn Aanes, et al

ClinicoEconomics and Outcomes Research 2011, 3:73-78

Published Date: 21 March 2011

Original Research

Adherence and persistence with branded antidepressants and generic SSRIs among managed care patients with major depressive disorder

Xianchen Liu, Yi Chen, Douglas E Faries, et al

ClinicoEconomics and Outcomes Research 2011, 3:63-72

Published Date: 15 March 2011

Original Research

Cost–utility analysis of prophylaxis versus treatment on demand in severe hemophilia A

Giorgio L Colombo, Sergio Di Matteo, Maria Elisa Mancuso, et al

ClinicoEconomics and Outcomes Research 2011, 3:55-61

Published Date: 14 March 2011

Review

Adherence to antihypertensive medications and health outcomes among newly treated hypertensive patients

Luca Degli Esposti, Stefania Saragoni, Silvia Benemei, et al

ClinicoEconomics and Outcomes Research 2011, 3:47-54

Published Date: 7 March 2011

Review

A cost-effectiveness analysis of different therapies in patients with chronic hepatitis B in Italy

Giorgio L Colombo, Giovanni B Gaeta, Mauro Viganò, et al

ClinicoEconomics and Outcomes Research 2011, 3:37-46

Published Date: 15 February 2011

Review

Biosimilar medicines and cost-effectiveness

Steven Simoens

ClinicoEconomics and Outcomes Research 2011, 3:29-36

Published Date: 10 February 2011

Original Research

Indirect treatment comparison of bevacizumab + interferon-α-2a vs tyrosine kinase inhibitors in first-line metastatic renal cell carcinoma therapy

Gerald HJ Mickisch, Björn Schwander, Bernard Escudier, et al

ClinicoEconomics and Outcomes Research 2011, 3:19-27

Published Date: 25 January 2011

Original Research

The costs of hospitalization in patients with acute exacerbation of chronic obstructive pulmonary disease

Sevket Ozkaya, Serhat Findik, Atilla Guven Atici

ClinicoEconomics and Outcomes Research 2011, 3:15-18

Published Date: 17 January 2011

Original Research

Decline in hospitalization risk and health care cost after initiation of depot antipsychotics in the treatment of schizophrenia

Xiaomei Peng, Haya Ascher-Svanum, Douglas Faries et al

ClinicoEconomics and Outcomes Research 2011, 3:9-14

Published Date: 11 January 2011

Original Research

The cost-effectiveness of venous-converted acid-base and blood gas status in pulmonary medical departments

Lars Oddershede, Sabrina Storgaard Petersen, Asgerd Krogh Kristensen, et al

ClinicoEconomics and Outcomes Research 2011, 3:1-7

Published Date: 16 December 2010

Review

Inpatient charges and mental illness: Findings from the Nationwide Inpatient Sample 1999–2007

Jim E Banta, Ivorie Belk, Kedon Newton, et al

ClinicoEconomics and Outcomes Research 2010, 2:149-158

Published Date: 11 October 2010

Original Research

Cost effectiveness of cord blood versus bone marrow and peripheral blood stem cells

Thomas Bart

ClinicoEconomics and Outcomes Research 2010, 2:141-147

Published Date: 5 October 2010

Original Research

Testing the generalizability of national reimbursement rates with respect to local setting: the costs of abdominal aortic aneurysm surgery in Denmark

Søren Løvstad Christensen, Mette Kjoelby, Lars Ehlers

ClinicoEconomics and Outcomes Research 2010, 2:135-139

Published Date: 14 September 2010

Review

Pharmacotherapy in the management of early Parkinson’s disease: cost-effectiveness and patient acceptability

Esther Cubo

ClinicoEconomics and Outcomes Research 2010, 2:127-134

Published Date: 6 September 2010

Original Research

On the decision rules of cost-effective treatment for patients with diabetic foot syndrome

John E Goulionis, Athanassios Vozikis, VK Benos, et al

ClinicoEconomics and Outcomes Research 2010, 2:121-126

Published Date: 17 August 2010

Review

Antihypertensive therapy among newly treated patients: An analysis of adherence and cost of treatment over years

Luca Degli Esposti, Stefania Saragoni, Paolo Batacchi, et al

ClinicoEconomics and Outcomes Research 2010, 2:113-120

Published Date: 28 July 2010

Original Research

The significance of presenteeism for the value of lost production: the case of rheumatoid arthritis

Rikke Søgaard, Jan Sørensen, Louise Linde, et al

ClinicoEconomics and Outcomes Research 2010, 2:105-112

Published Date: 16 July 2010

Original Research

Impact of disability on different domains of health-related quality of life in the noninstitutionalized general population

Javier Mar, Isabel Larrañaga, Arantzazu Arrospide, et al

ClinicoEconomics and Outcomes Research 2010, 2:97-103

Published Date: 14 July 2010

Review

Cost effectiveness and quality of life considerations in the treatment of hepatitis C infection

H Jafferbhoy, W Gashau, JF Dillon

ClinicoEconomics and Outcomes Research 2010, 2:87-96

Published Date: 14 July 2010

Original Research

Cost-effectiveness analysis of corticosteroid inhaler devices in primary care asthma management: A real world observational study

Linda Kemp, John Haughney, Neil Barnes, et al

ClinicoEconomics and Outcomes Research 2010, 2:75-85

Published Date: 1 July 2010

Review

Clinical and economic considerations of antiobesity treatment: a review of orlistat

Armineh Zohrabian

ClinicoEconomics and Outcomes Research 2010, 2:63-74

Published Date: 5 July 2010

Review

Pharmacoeconomic considerations in the treatment of breast cancer

Athanasios Pallis, Vasiliki Tsiantou, Efi Simou, et al

ClinicoEconomics and Outcomes Research 2010, 2:47-61

Published Date: 15 June 2010

Review

Rituximab in the treatment of B-cell non-Hodgkin lymphoma, focus on outcomes and comparative effectiveness

Firas Badin, John Hayslip

ClinicoEconomics and Outcomes Research 2010, 2:37-45

Published Date: 7 April 2010

Original Research

Evaluating the cost-effectiveness of tiotropium versus salmeterol in the treatment of chronic obstructive pulmonary disease

Shalini Naik, Khalid M Kamal, Patricia A Keys, et al

ClinicoEconomics and Outcomes Research 2010, 2:25-36

Published Date: 9 March 2010

Original Research

Cost-effectiveness analysis of intravenous levetiracetam versus intravenous phenytoin for early onset seizure prophylaxis after neurosurgery and traumatic brain injury

Rashid Kazerooni, Mark Bounthavong

ClinicoEconomics and Outcomes Research 2010, 2:15-23

Published Date: 5 March 2010

Perspectives

Use of electronic medical records in oncology outcomes research

Gena Kanas, Libby Morimoto, Fionna Mowat, et al

ClinicoEconomics and Outcomes Research 2010, 2:1-14

Published Date: 24 February 2010

Review

Economic considerations for bariatric surgery and morbid obesity

Eldo E Frezza, Mitchell Wacthell, Bradley Ewing

ClinicoEconomics and Outcomes Research 2009, 1:79-83

Published Date: 10 December 2009

Review

Assessing cost-effectiveness in the management of multiple sclerosis

Ceri J Phillips, Ioan Humphreys

ClinicoEconomics and Outcomes Research 2009, 1:61-78

Published Date: 18 November 2009

Review

A cost–utility analysis of etanercept for the treatment of moderate-to-severe psoriasis in Italy

Giorgio L Colombo, Sergio Di Matteo, Ketty Peris, Maria Concetta Fargnoli, et al.

ClinicoEconomics and Outcomes Research 2009, 1:53-59

Published Date: 15 October 2009

Review

Clinical efficacy issues in the treatment of multiple sclerosis: update of natalizumab

Francesco Patti, Angelo Pappalardo

ClinicoEconomics and Outcomes Research 2009, 1:45-51

Published Date: 21 August 2009

Review

Economic considerations in the treatment of invasive aspergillosis: a review of voriconazole pharmacoeconomic studies

Kem P Krueger, A Christie Nelson

ClinicoEconomics and Outcomes Research 2009, 1:35-43

Published Date: 10 August 2009

Review

Smoking cessation: an economic analysis and review of varenicline

Michele A Faulkner

ClinicoEconomics and Outcomes Research 2009, 1:25-34

Published Date: 24 June 2009

Review

Management strategies and cost effectiveness in the prevention of cervical cancer

Smita R Prasad

ClinicoEconomics and Outcomes Research 2009, 1:17-23

Published Date: 5 June 2009

Original Research

Body mass characteristics of hip osteoarthritis patients experiencing aseptic loosening, periprosthetic fractures, dislocation, and infections after total hip replacement

Ray Marks

ClinicoEconomics and Outcomes Research 2009, 1:7-16

Published Date: 15 May 2009

Case report

Breast cancer quality of life evaluation in Mexican Women at La Raza Hospital, Mexico City: A preliminary approach

Jacobo Alejandro Gómez-Rico, Marina Altagracia-Martínez, Jaime Kravzov-Jinich, Rosario Cárdenas-Elizalde, Juan Carlos Hinojosa-Cruz, Consuelo Rubio-Poo

ClinicoEconomics and Outcomes Research 2009, 1:1-6

Published Date: 30 November 2008